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Helicobacter	   pylori	   is	   a	  Gram-­‐negative,	   pathogenic,	  microaerobic	  bacterium	  colonizing	  the	  gastric	  epithelium	  of	  about	  50%	  of	  the	  world	  population.	  It	  is	  responsible	  for	  type	  B	  gastritis,	   peptic	   ulcers,	   and	   for	   increasing	   the	   risk	   of	   gastric	   carcinoma.	   Successful	  interaction	  of	  the	  pathogen	  with	  its	  host	  does	  not	  only	  require	  specific	  virulence	  factors,	  but	   depends	   also	   on	   its	   capability	   to	   cope	  with	   nutrient	   supply	   and	   stress	   conditions	  found	   in	   the	   host.	   Previous	   genome	   analyses	   revealed	   that	   genes	   encoding	   L-­‐proline	  transport	  (putP)	  and	  metabolizing	  proteins	  (putA)	  are	  essential	  for	  H.	  pylori	  for	  gastric	  colonization.	  Furthermore,	  it	  has	  been	  shown	  that	  L-­‐proline	  is	  present	  in	  high	  amounts	  in	  humans	  infected	  with	  H.	  pylori,	  which	  can	  be	  used	  as	  energy	  source	  by	  the	  bacteria.	  	  This	   research	   focuses	   on	   the	   mechanisms	   underlying	   the	   particular	   physiological	  significance	  of	  L-­‐proline	  and	  L-­‐proline-­‐specific	  systems	  for	  H.	  pylori.	  First,	  the	  putative	  proline	  transporter	  PutP	  of	  H.	  pylori	  (HpPutP)	  was	  functionally	  characterized.	  The	  gene	  
HpputP	  was	  cloned	  from	  strain	  P12	  and	  heterologously	  expressed	  in	  E.	  coli.	  HpputP	  was	  shown	  to	  complement	  an	  E.	  coli	  putP	  deletion	  mutant.	  HpPutP	  was	  purified	  by	  affinity	  chromatography	   and	   reconstituted	   into	   proteoliposomes.	   Functional	   analyses	   with	  proteoliposomes	   demonstrated	   that	   the	   activity	   of	   HpPutP	   depends	   on	   an	  electrochemical	   sodium	   gradient.	   Kinetic	   parameters	   of	   the	   Na+/proline	   symport	  process	   were	   determined	   and	   found	   to	   be	   in	   the	   same	   order	   of	   magnitude	   as	   the	  parameters	  of	  PutP	  of	  E.	  coli	  (EcPutP).	  Furthermore,	  sites	  known	  from	  EcPutP	  to	  be	  of	  functional	  significance	  were	  investigated	  in	  HpPutP.	  By	  this	  means,	  residues	  potentially	  involved	  in	  sodium	  or	  proline	  binding	  and/or	  translocation	  were	  identified	  in	  HpPutP.	  Analysis	   of	   proline	   transport	   in	   H.	   pylori	   wild	   type	   showed	   accumulation	   of	  extracellularly	  applied	  L-­‐proline,	  and	  deletion	  of	  the	  putative	  transporter	  gene	  inhibited	  transport	  completely.	  Kinetic	  parameters	  for	  proline	  and	  sodium	  measured	  in	  H.	  pylori	  differed	  from	  those	  measured	  in	  E.	  coli.	  	  This	  phenomenon	  is	  explained	  by	  differences	  in	  membrane	   composition	   of	   the	   strains.	   Deletion	   mutants	   for	   HpputP,	   HpputA	   and	  
HpputAP	   showed	   an	   altered	   energy	   status,	   and	   contrary	   to	   the	   wild	   type	   were	   non-­‐motile.	  FlaA	  gene	  expression	  was	  found	  to	  be	  impaired,	  and	  phenotypic	  characterization	  demostrated	   the	   absence	   of	   flagella.	   	   Since	   motility	   is	   essential	   for	   virulence,	   these	  phenomena	  may	   represent	   the	   reason	   for	   the	   previously	   reported	   loss	   of	   infectivity.	  Complemented	   mutants	   were	   able	   to	   restore	   L-­‐proline	   transport,	   ATP	   levels	   and	  partially	  flagella	  structures.	  Therefore,	  proline	  availability	  is	  crucial	  for	  the	  course	  of	  H.	  






1.	  INTRODUCTION	  	  
1.1	  Helicobacter	  pylori:	  History	  and	  general	  description	  By	  the	  late	  19th	  and	  early	  20th	  centuries,	  several	  investigators	  reported	  the	  presence	  of	  spiral	  microorganisms	  in	  the	  stomachs	  of	  animals.	  The	  Italian	  Guilio	  Bizzozero	  was	  the	  first	   one	   who	   observed	   and	   described	   spiral	   organisms	   in	   the	   stomach	   of	   dogs	  (Bizzozero,	  1893).	  Soon	  afterwards,	   the	  German	  Hugo	  Salomon	  confirmed	  Bizzozero’s	  work	  (Salomon	  H,	  1896).	  	  In	  the	  beginning	  of	  the	  twentieth	  century	  another	  German,	  W.	  Krienitz,	  detected	  spiral	  germs	   in	   the	   stomachs	   of	   patients	   with	   gastric	   carcinoma	   (Krienitz	  W,	   1906).	   These	  bacteria,	  however,	  were	  thought	  to	  be	  contaminants	  from	  digested	  food	  rather	  than	  true	  gastric	  colonizers	  until	  the	  early	  1980s.	  	  In	   1983,	   Barry	   Marshall	   and	   Robin	   Warren	   described	   the	   successful	   isolation	   and	  culture	   of	   a	   spiral	   bacterial	   species	   present	   in	   the	   stomach	   of	   58	   of	   100	   patients	  analyzed	  in	  which	  bacteria	  colonization	  was	  strongly	  associated	  to	  histological	  changes.	  This	   bacterium	  was	   later	   known	   as	  Helicobacter	   pylori	   (Warren	   J	   R	   and	   B	   J	  Marshall	  1983).	   Self-­‐ingestion	   experiments	   by	  Marshall	   (Marshall	   B	   J,	   et	   al.,	   1985)	   and	  Morris	  (Morris	  A	  and	  G	  Nicholson,	  1987)	  and	   later	  with	  volunteers	   (Morris	  A	   J.,	  et	  al.,	   1991)	  demonstrated	   that	   these	   bacteria	   can	   colonize	   the	   human	   stomach,	   thereby	   inducing	  inflammation	   of	   the	   gastric	   mucosa.	   These	   initial	   data	   strongly	   stimulated	   further	  research,	   which	   showed	   that	   gastric	   colonization	   with	   H.	   pylori	   can	   lead	   to	   several	  upper	  gastrointestinal	  disorders,	  such	  as	  chronic	  gastritis,	  peptic	  ulcer	  disease,	  gastric	  mucosa	  associated	  lymphoid	  tissue	  (MALT),	  and	  gastric	  cancer	  (Ernst	  P	  B	  and	  B	  D	  Gold,	  2000).	  This	  discovery	  resulted	  in	  the	  awarding	  of	  the	  2005	  Nobel	  Prize	  in	  Physiology	  or	  Medicine	   to	   Robin	  Warren	   and	   Barry	   Marshall	   for	   their	   “Discovery	   of	   the	   bacterium	  
Helicobacter	  pylori	  and	  its	  role	  in	  gastritis	  and	  peptic	  ulcer	  disease.”	  The	   organism	   was	   initially	   named	   “Campylobacter-­‐like	   organism,”	   “gastric	  
Campylobacter-­like	   organism,”	   “Campylobacter	   pyloridis,”	   and	   “Campylobacter	   pylori”	  but	   is	   now	   named	  Helicobacter	   pylori	   in	   recognition	   of	   the	   fact	   that	   this	   organism	   is	  distinct	  from	  members	  of	  the	  genus	  Campylobacter	  (Goodwin	  C	  S,	  et	  al.,	  1989).	  	  	  The	   genus	   Helicobacter	   belongs	   to	   the	   ε	   subdivision	   of	   the	   Proteobacteria,	   order	  
Campylobacterales,	  family	  Helicobacteraceae.	  To	  date,	  the	  genus	  Helicobacter	  consists	  of	  over	   20	   recognized	   species,	   with	  many	   species	   awaiting	   formal	   recognition	   (Fox	   J	   G,	  2002).	   Members	   of	   the	   genus	   Helicobacter	   are	   all	   microaerophilic	   organisms	   and	   in	  most	   cases	  are	  catalase	  and	  oxidase	  positive,	  and	  many	  but	  not	  all	   species	  are	  urease	  positive.	   Helicobacter	   species	   can	   be	   subdivided	   into	   two	   major	   lineages,	   the	   gastric	  
Helicobacter	  species	  and	  the	  enterohepatic	  (nongastric)	  Helicobacter	  species.	  	  The	  organism	  measures	  2	  to	  4	  µm	  in	  length	  and	  0.5	  to	  1	  µm	  in	  width.	  Although	  usually	  spiral-­‐shaped	  (Figure	  1),	  it	  can	  appear	  also	  as	  a	  rod,	  while	  coccoid	  shapes	  appear	  after	  prolonged	  in	  vitro	  culture	  or	  antibiotic	  treatment	  (Kusters	  J	  G,	  et	  al.,	  1997).	  It	  has	  been	  suggested	  that	  coccoid	  forms	  may	  represent	  a	  viable,	  nonculturable	  state	  (Enroth	  H,	  et	  






	  	  	  	  	  	  	  
Figure	   1.	   	   Helicobacter	   pylori	   morphology	   (A)	   Scanning	  electron	   micrograph	   of	   H.	   pylori	   shows	   the	   gently	   curved	  morphology,	   multiple	   bipolar	   flagella,	   and	   absence	   of	  periplasmic	   fibers.	  Bar,	   1	  μm.	  Photo	   courtesy	  of	  Adrian	  Lee,	  Jani	   O'Rourke,	   and	   Lucinda	   Thompson.	   “Reproduced	   with	  permission	   from	   the	   American	   Society	   for	   Microbiology".	  [Clin.	   Microbiol.	   Rev.	   14(1):59.DOI:10.1128/CMR.14.1.59-­‐97.2001.]	  (Solnick	  JV,	  Schauer	  DB),	  copyright	  (2010)	  	  The	  size	  of	  the	  sequenced	  H.	  pylori	  genomes	  is	  approximately	  1.7	  Mbp,	  with	  an	  average	  G+C	   content	   of	   39%	   (Tomb	   J	   F	   et	   al.,	   1997).	   H.	   pylori	   is	   genetically	   heterogeneous,	  suggesting	  a	  lack	  of	  clonality.	  It	  has	  been	  estimated	  that	  every	  H.	  pylori-­‐positive	  subject	  carries	   a	   distinct	   strain	   (Kansau	   I,	   et	   al.,	   1996),	   although	   differences	  within	   relatives	  may	   be	   small.	   The	   genetic	   heterogeneity	   is	   possibly	   an	   adaptation	   of	  H.	   pylori	   to	   the	  gastric	   conditions	   of	   its	   host,	   as	  well	   as	   to	   the	   distinct	   patterns	   of	   the	   host-­‐mediated	  immune	  response	  to	  H.	  pylori	  infection	  (Kuipers	  E	  J	  et	  al.,	  2000)	  
	  
H.	  pylori	   is	  a	  microaerophilic	  bacterium	  that	  does	  not	  tolerate	  high	  oxygen	  conditions,	  but	  it	  requires	  a	  minimum	  of	  2%	  O2	  (Mendz	  G	  L,	  et.	  al.,	  1997).	  This	  is	  because	  H.	  pylori	  uses	  oxygen	  as	  a	  terminal	  electron	  acceptor.	  H.	  pylori	  cannot	  utilize	  alternative	  electron	  acceptors,	   such	   as	   nitrate	   or	   formate,	   although	   there	   is	   a	   single	   report	   on	   anaerobic	  growth	  of	  H.	  pylori	  using	  fumarate	  (Smith	  M	  A	  and	  D	  I	  Edwards,	  1995).	  H.	  pylori	  requires	  complex	   growth	   media	   which	   are	   often	   supplemented	   with	   blood	   or	   serum	   and	   the	  cultures	  require	  from	  5	  to	  10%	  CO2	  and	  high	  humidity.	  
	  
H.	   pylori	   has	   a	   stripped-­‐down	  metabolic	   route	  with	   very	   few	   redundancies	   and	   lacks	  biosynthetic	   pathways	   for	   some	   amino	   acids.	   Therefore,	   H.	   pylori	   is	   auxotrophic	   for	  several	  amino	  acids,	  supporting	  the	  idea	  that	  its	  growth	  in	  vivo	  is	  strictly	  dependent	  on	  the	   gastric	   environment.	   The	  minimal	   amino	   acid	   requirements	   of	   this	   bacterium	   are	  arginine,	  histidine,	  isoleucine,	  leucine,	  methionine,	  phenylalanine,	  and	  valine,	  with	  some	  strains	  also	  requiring	  alanine	  or	  serine	  (Nedenskov	  P,	  1994;	  Reynolds	  D	  J	  and	  Penn	  C	  W,	  1994).	  Besides,	  H.	  pylori	  is	  urease,	  catalase,	  and	  oxidase	  positive,	  characteristics	  which	  are	  often	  used	   in	   identification	  of	  H.	  pylori.	  The	  bacterium	  can	  catabolize	  glucose,	  and	  both	   genomic	   and	   biochemical	   information	   indicates	   that	   other	   sugars	   cannot	   be	  catabolized	   by	  H.	   pylori	   (Berg	   D	   E,	   et	   al.,	   1997;	   Marais	   A,	   et	   al.,	   1999;	   Nedenskov	   P,	  
1994).	  	  	  	  
1.1.1	  Epidemiology	  and	  Transmission	  





recent	   decades,	   more	   accentuated	   in	   wealthy	   western	   societies.	   Despite	   a	   general	  decline	   in	   the	   incidence	   of	   gastric	   cancer,	   it	   remains	   the	   fourth	  most	   common	   cancer	  and	  second	  leading	  cause	  of	  cancer-­‐related	  deaths	  worldwide.	  Several	  factors	  must	  be	  considered	  to	  explain	  the	  cause	  of	  the	  geographic	  differences	  in	  the	   disease	   pattern,	   like	   host-­‐related	   factors	   (host	   genetics),	   the	   duration	   of	   infection	  (age	  at	  acquisition)	  and/or	  environmental	  factors	  (poor	  nutrition	  in	  childhood,	  high	  salt	  intake	   and	   nitrate	   consumption)	   (Yamaoka	   Y,	   2010).	   Besides,	   H.	   pylori	   is	   a	   highly	  heterogeneous	  bacterium	  which	  virulence	  has	  also	  changed	  geographically	  since	  it	  has	  co-­‐evolved	  with	  humans	  at	  least	  since	  they	  migrated	  out	  of	  Africa	  approximately	  58,000	  years	  ago	  and	  probably	  throughout	  their	  evolution	  (Figure	  2).	  	  
	  	  
Figure	  2.	  Distribution	  of	  Helicobater	  pylori	  genotypes.	  H.	  pylori	  is	  predicted	  to	  have	  spread	  from	  East	  Africa	  over	  the	  same	  time	  period	  as	  anatomically	  modern	  humans	  (~58,000	  years	  ago),	  and	  has	  remained	  intimately	  associated	  with	  their	  human	  hosts	  ever	  since.	  Estimated	  global	  patterns	  of	  H.	  pylori	  migration	  are	  indicated	  by	  arrows	  and	  the	  numbers	  show	  the	  estimated	  time	  since	  they	  migrated	  (years	  ago).	  The	  broken	   arrow	   indicates	   an	   unconfirmed	   migration	   pattern.	   Reprinted	   by	   permission	   from	   Macmillan	  Publishers	  Ltd:	  [Nat	  Rev	  Gastroenterol	  Hepatol]	  (Yamaoka,	  Y.),	  copyright	  (2010)	  	  The	   infection	   is	  acquired	  by	  oral	   ingestion	  of	   the	  bacterium	  and	   is	  mainly	  transmitted	  within	   families	   in	   early	   childhood	   (Feldman	   R	   A,	   2001;	   Rowland	   M,	   1999).	   It	   seems	  likely	   that	   in	   industrialized	   countries	   direct	   transmission	   from	   person	   to	   person	   by	  vomitus,	   saliva,	   or	   feces	  predominates;	   additional	   transmission	   routes,	   such	   as	  water,	  may	  be	  important	  in	  developing	  countries	  (Parsonnet	  J,	  1999;	  Goodman	  K	  J,	  1996)	  	  	  
1.1.2	  Pathogenesis	  of	  Infection	  Normally	   gastric	  mucosa	   is	  well	   protected	   against	   bacterial	   infections	   but	  H.	   pylori	   is	  highly	  adapted	  to	  this	  ecologic	  niche,	  with	  a	  unique	  array	  of	  features	  that	  permit	  entry	  into	  the	  mucus,	  swimming	  and	  spatial	  orientation	  in	  the	  mucus,	  attachment	  to	  epithelial	  cells,	   evasion	   of	   the	   immune	   response,	   and,	   as	   a	   result,	   persistent	   colonization	   and	  transmission.	  There	   is	  very	  strong	  evidence	   that	  H.	  pylori	   increases	   the	   risk	  of	  gastric	  cancer.	   Therefore,	  H.	   pylori	  has	   been	   classified	   as	   a	   type	   I	   (definite)	   carcinogen	   since	  1994,	  mainly	  on	  the	  basis	  of	  large	  seroepidemiologic	  case–control	  studies	  (Parsonnet	  J,	  





infection	  is	  highly	  variable	  and	  is	  influenced	  by	  both	  microbial	  and	  host	  factors	  (Figure	  3).	  	  	  
	  
Figure	   3.	  Natural	   progression	   of	  H.	   pylori	   infection.	   Infection	   usually	   occurs	   during	   childhood	   and	  causes	   symptomatic	   acute	   gastritis.	   Because	   the	   symptoms	   of	   acute	   gastritis	   are	   non-­‐specific	   and	  transient,	  a	  diagnosis	  is	  rarely	  made	  at	  this	  stage.	  Acute	  infection	  transforms	  to	  chronic	  active	  gastritis	  in	  most	  patients	  and	  persists	  for	  decades	  or	  is	  life-­‐long.	  The	  infection	  can	  take	  multiple	  courses.	  Most	  people	  that	   are	   infected	   with	   H.	   pylori	   will	   never	   develop	   symptomatic	   disease.	   10–15%	   will	   develop	   ulcer	  disease	  (gastric	  or	  duodenal	  ulcer),	  approximately	  1%	  will	  develop	  gastric	  adenocarcinoma,	  and	  a	  small	  group	  of	  patients	  will	  develop	  gastric	  MALT	  lymphoma.	  Reproduced	  with	  permission	  from	  (Suerbaum	  S,	  Michetti	  P.2001),	  Copyright	  Massachusetts	  Medical	  Society.	  	  	  Production	   of	   urease	   and	  motility	   are	   essential	   for	   the	   first	   step	   of	   infection.	   In	   one	  hand,	  urease	  hydrolyzes	  urea	  into	  carbon	  dioxide	  and	  ammonia,	  thereby	  permitting	  H.	  





the	   epithelial	   cell,	   CagA	   is	   phosphorylated	   and	   binds	   to	   SHP-­‐2	   tyrosine	   phosphatase,	  leading	   to	  a	  growth	   factor–like	   cellular	   response	  and	  cytokine	  production	  by	   the	  host	  cell	  (Figure	  4).	  Patients	  with	  antral-­‐predominant	  gastritis,	  the	  most	  common	  form	  of	  H.	  pylori	  gastritis,	  are	   predisposed	   to	   duodenal	   ulcers,	   whereas	   patients	   with	   corpus-­‐predominant	  gastritis	  and	  multifocal	  atrophy	  are	  more	   likely	  to	  have	  gastric	  ulcers,	  gastric	  atrophy,	  intestinal	  metaplasia,	  and	  ultimately	  gastric	  carcinoma.	  	  
	  	  





Six	  complete	  H.	  pylori	  genome	  sequences	  are	  currently	  available	  (Tomb	  J	  F	  and	  White	  O	  
et	  al.	  1997;	  Alm,	  R	  A,	  et	  al.	  1999;	  Oh	  JD	  et	  al.	  2006).	  Of	  the	  1590	  predicted	  genes	  in	  H.	  
pylori	   two	  thirds	  were	  assigned	  biological	  roles,	  but	  about	  one	  third	  did	  not	  show	  any	  database	  match.	  Our	  understanding	  of	  the	  genes	  necessary	  for	  the	  specific	  adaptation	  of	  the	   pathogen	   to	   the	   gastric	   mucosa	   is	   still	   very	   limited	   despite	   the	   description	   of	  essential	  and	  nonessential	  genes	  in	  vitro	  (Chalker	  A	  F	  2001;	  Jenks	  P	  J,	  2001).	  Therefore	  we	  need	  to	  exploit	  the	  information	  from	  the	  H.	  pylori	  genome	  sequences	  as	  performed	  for	  other	  pathogens	  (Hutchison	  C	  A,	  et	  al.	  1999;	  Akerley	  B	  J	  et	  al.	  2002).	  	  
	  
1.1.3	  Motility	  as	  an	  important	  virulent	  factor	  Motility	  is	  an	  essential	  colonization	  factor	  for	  H.	  pylori	  in	  experimental	  infection	  models	  (Eaton	  K,	  et	  al.,	  1992;	  Eaton	  K	  A,	  et	  al.,	  1996;	  Mankoski	  R,	  et	  al.,	  1999).	  Because	  of	  the	  contribution	  of	  flagella	  to	  virulence,	  the	  genomic	  basis	  of	  H.	  pylori	  flagellum	  production	  is	   therefore	  of	  considerable	   interest.	  As	  with	  enteric	  bacteria,	   the	  H.	  pylori	   flagella	  are	  composed	  of	  three	  structural	  elements:	  a	  basal	  body	  which	  serves	  as	  a	  cell	  anchor	  and	  contains	   the	   proteins	   required	   for	   rotation	   and	   chemotaxis,	   a	   curved	   hook	   structure	  composed	   of	   the	   FlgE	   protein	   (O'Toole	   P	   W,	   et	   al.,	   2000),	   and	   the	   helically	   shaped	  flagellar	   filament.	   Thus	   far,	   only	   a	   few	   of	   the	   numerous	   proteins	   involved	   in	   the	  formation	   of	   this	   complex	   structure	   have	   been	   characterized	   in	   some	   detail;	   these	  include	  the	  components	  of	   the	  flagellar	   filament	  FlaA	  (Leying	  H,	  et	  al.,	  1992)	  and	  FlaB	  (Suerbaum	  S	  et	  al.,	  1993),	  which	  are	  expressed	  by	  cultured	  cells	  to	  very	  different	  levels,	  FlaA	  being	  the	  predominant	  subtype.	  	  As	  with	  other	  bacteria,	  flagellar	  biosynthesis	  is	  a	  hierarchical	  process	  that	  is	  subject	  to	  temporal	  and	  growth	  phase	  regulation	  (Spohn	  and	  Scarlato,	  1999;	  Niehus	  E	  et	  al.,	  2004;	  Josenhans	   C	   et	   al.,	   2002)	   involving	   sequential	   activation	   of	   approximately	   40	   genes	  (Niehus	  E	  et	  al.,	  2004;	  Macnab	  R	  M,	  2003).	  Expression	  of	  flagellar	  genes	  is	  controlled	  by	  at	   least	   three	   RNA	   polymerase	   sigma	   factors,	   σ80,	   σ54,	   and	   σ28	   (Alm	   R	   A,	   1999;	   Beier	  D;1998	  Tomb	  J	  F,	  1997),	  and	  a	  two-­‐component	  system	  for	  σ54-­‐regulated	  genes	  (Spohn	  G	  and	  V	  Scarlato,	  1999).	  A	  whole-­‐genome	  microarray	   analysis	   of	   strains	  mutated	   in	   flagellar	   regulatory	   genes	  (rpoN,	  flgR,	  flhA,	  flhF,	  HP0244)	  was	  performed	  to	  elucidate	  the	  complex	  transcriptional	  circuitry	   of	   flagellar	   biosynthesis	   and	   therefore	   the	   establishment	   of	   a	   model	   for	  flagellar	   gene	   regulation	   in	   H.	   pylori.	   This	   study	   revealed	   three	   different	   classes	   of	  flagella	  genes	  that	  are	  regulated	  by	  three	  different	  σ	  factors.	  Class	  1	  gene	  expression	  is	  controlled	  by	  the	  σ80	  factor,	  while	  Class	  2	  genes	  are	  controlled	  by	  the	  σ54	  factor	  (RpoN),	  and	  class	  3	  genes	  are	  expressed	  by	  the	  σ28-­‐FlgM-­‐controlled	  system.	  Seven	  novel	  genes	  dependent	   on	   σ54	  were	   identified	   (Niehus	   E	   et	   al.,	   2004)	   and	   no	  master	   regulator	   of	  flagellar	  biosynthesis	  (such	  as	  the	  enterobacterial	  flhCD	  genes)	  was	  found	  (Niehus	  E	  et	  







Figure	  5.	  Current	  model	  of	  regulation	  pathways	  in	  flagellar	  biosynthesis	  of	  H.	  pylori.	  Three	  different	  classes	  of	  flagellar	  genes	  are	  governed	  by	  the	  housekeeping	  sigma	  factor	  σ80	  (class	  1)	  and	  the	  alternative	  sigma	  factors	  σ54	  (class	  2)	  and	  σ28	  (class	  3).	  A	  number	  of	  intermediate	  genes	  controlled	  by	  more	  than	  one	  promoter	  are	  grouped	  in	  a	  separate	  category.	  Class	  1	  flagellar	  genes	  comprise,	  among	  others,	  most	  of	  the	  major	  regulatory	  genes	  of	  the	  flagellar	  system.	  The	  list	  of	  putative	  class	  1	  genes	  is	  not	  complete,	  as	  these	  regulons	  have	  not	  been	  investigated	  in	  detail.	  Transcription	  of	  class	  2	  genes	  is	  governed	  by	  RpoN,	  assisted	  by	   the	   histidine	   kinase	   HP0244	   (FlgS)	   and	   the	   response	   regulator	   FlgR.	   The	   class	   of	   RpoN-­‐dependent	  genes	  could	  be	  extended	  by	  a	  number	  of	  novel	  genes	   indicated	  by	  HP	  numbers.	  FlhA	  and	  FlhF	  are	  both	  necessary	  for	  full	  transcription	  of	  flagellar	  classes	  2	  and	  3	  and	  the	  intermediate	  class.	  FlgM	  plays	  a	  role	  in	  the	  transcriptional	  block	  of	  class	  2	  and	  3	  genes	  in	  flhA	  mutants,	  but	  only	  in	  the	  feedback	  block	  of	  class	  3	  genes	   in	   flhF	  mutants.	  A	  common	  mechanism	  of	   feedback	   inhibition	  on	  class	  3	  might	  be	  mediated	  by	  a	  deficient	   basal	   body	   via	   FlgM.	   Reproduced	  with	   permission	   from	   (Niehus,	   E.	   et	   al.,.2004),	   Copyright©	  2004	  John	  Wiley	  and	  Sons.	  
	  





essential	  for	  H.	  pylori	  to	  colonize	  in	  vivo,	  indicating	  that	  H.	  pylori	  apparently	  relies	  on	  the	  exogenous	  uptake	  of	   these	  amino	  acid	   from	   the	   stomach	  mucosa.	   Such	  an	  amino	  acid	  exchange	  between	  bacteria	  and	  host	   is	   frequently	  observed	   in	  primary	  and	  secondary	  symbionts	  of	  plants	  and	  animals	  (Graf	  J	  and	  E	  G	  Ruby,	  1998).	  	  The	  carbohydrate	  utilized	  by	  H.	  pylori	  as	  the	  energy	  source	  has	  originally	  been	  reported	  to	  be	  only	  glucose	  (Mendz	  G	  L,	  et	  al.,	  1993).	  The	  whole-­‐genome	  analysis	  of	  H.	  pylori	  has	  supported	  these	  findings	  (Tomb	  J	  F	  et	  al.,	  1997).	   	  However,	  more	  recent	  investigations	  indicate	  that	  glucose	  is	  not	  the	  preferred	  energy	  substrate	  of	  H.	  pylori.	  	  This	  was	  shown	  in	  experiments	  where	  glucose	  added	  to	  the	  culture	  medium	  composed	  of	  a	  mixture	  of	  amino	  acids	  was	  not	  utilized	  until	  the	  amino	  acids	  were	  significantly	  depleted	  (Mendz	  G	  L	  et	  al.,	  1993;	  Mendz	  G	  L	  and	  S	  L	  Hazell,	  1995).	  These	  results	  suggested	  that	  H.	  pylori	  can	  grow	  employing	  amino	  acids	  as	  main	  energy	  source.	  Therefore,	  Nagata	  and	  coworkers	  in	  2003	  investigated	  the	  respiratory	  activity	  of	  intact	  H.	  pylori	  cells	  with	  alanine,	  serine	  and	  proline,	  and	  other	  amino	  acids	  of	  which	  both	  D-­‐	  and	  L-­‐isomers	  serve	  as	  respiratory	  substrates.	   They	   described	   a	   high	   rate	   of	   utilization	   of	   L-­‐serine	   and	   L-­‐proline	   as	  respiratory	   substrates,	   an	   unusual	   high	   content	   of	   L-­‐proline	   in	  H.	   pylori	   cells,	   that	   L-­‐proline	   predominated	   in	   samples	   of	   human	   gastric	   juice	   and	   that	   the	   content	   of	   L-­‐proline	  in	  infected	  specimens	  was	  significantly	  higher	  than	  that	  in	  uninfected	  ones	  (up	  to	  10mg	  per	  g	  of	  gastric	  juice)	  (Nagata	  K	  et	  al.,	  2003).	  	  	  A	  possible	  explanation	  for	  the	  high	  L-­‐proline	  content	  in	  the	  stomach	  of	  infected	  persons	  is	   the	  secretion	  of	  a	  collagenase	  by	  H.	  pylori.	   Infection	  studies	   in	   the	  Mongolian	  gerbil	  (Meriones	   unguiculatus),	   a	   well-­‐established	   H.	   pylori	   animal	   model,	   was	   used	   to	  characterize	   this	   gene	   (HP0169),	   which	   was	   found	   to	   be	   essential	   for	   H.	   pylori	   to	  colonize	  in	  the	  gerbil	  stomach.	  	  This	  collagenase	  was	  verified	  as	  a	  novel	  virulence	  factor	  of	  H.	  pylori	   for	   stomach	  colonization	   (Kavermann,	  et	  al.	  2003).	  An	  abundant	   reservoir	  for	  proline	   is	   the	   collagen	  present	   in	   the	   extracellular	  matrix	   (EM),	   connective	   tissue,	  and	  bone	  (Phang	  J	  M,	  et	  al.	  2010).	  Therefore	  the	  collagen	  present	  in	  the	  EM	  in	  the	  gastric	  tissue	   could	   be	   the	   source	   of	   proline	   in	   the	   gastric	   juice.	   Besides,	   there	   is	   an	  enhancement	   of	   collagen	   turnover	   in	   stomach	   cancer	   that	   can	   be	   induced	   by	   the	  collagenase	  secretion	  during	  the	  H.	  pylori	  infection	  (Phang	  J	  M,	  et	  al.	  2010).	  	  	  	  
1.2.1	   Known	   effects	   of	   L-­proline	   transport	   and	   metabolism	   on	   bacteria-­host	  
interactions	  In	   general,	   L-­‐proline	   can	   be	   used	   for	   most	   of	   the	   living	   cells	   as	   a	   source	   of	   carbon,	  nitrogen	  and	  energy;	  can	  be	  a	  compatible	  solute	  during	  adaptation	  to	  osmotic	  stress;	  a	  modulator	   of	   the	   intracellular	   redox	   environment	   and	   scavenger	   of	   reactive	   oxygen	  species (Rodriguez	   R	   and	   R	   Redman,	   2005).	   In	   this	   way,	   previous	   studies	   have	  suggested	   that	   under	   high-­‐osmolarity	   growth	   conditions,	   proline	   accumulates	   and	  serves	  as	  an	  osmoprotectant	  for	  Staphylococcus	  aureus	  (Graham	  J	  E,	  and	  B	  J	  Wilkinson	  1992;	  Bae	  J-­‐H,	  and	  K	  J	  Miller	  1992.)	  and	  Bacillus	  subtilis	  (von	  Blohn	  et	  al.,	  1997)	  as	  well	  as	  Gram-­‐negative	  bacteria	  (Csonka	  L	  N,	  and	  A	  D	  Hanson	  1991;	  H	  Jung,	  2002).	  





disruption	  of	  the	  proline	  permease	  PutP	  by	  transposon	  insertion	  has	  a	  deleterious	  effect	  on	  proline	  uptake,	  which	  in	  turn	  affects	  the	  in	  vivo	  survival	  of	  S.	  aureus.	  Another	  example	  is	  Vibrio	  vulnificus,	  the	  causative	  agent	  of	  food-­‐borne	  deseases,	  which	  needs	   the	  gene	  product	  of	  putP	   for	   the	   adaption	   to	   changing	  osmolalities	  during	  host	  infection	   (Kim	   H	   J,	   et	   al.,	   2002).	   As	   mentioned	   before,	   L-­‐proline	   transport	   and	  metabolism	   is	   also	   important	   for	   interactions	   between	   Gram-­‐negative	   bacterial	  pathogens	   and	   hosts.	   In	   Francisella	   novicia	   proline	   is	   required	   for	   pulmonary	   and	  systematic	  infection	  of	  mice	  (Kraemer	  P	  S,	  et	  al.,	  2009).	  In	  Vibrio	  cholera	  it	  is	  important	  for	  initial	  steps	  in	  biofilm	  formation	  (monlayer	  formation)	  (Kapfhammer	  D	  et	  al.,	  2005).	  Also	   in	  E.	   coli	   and	   Salmonella	   typhimurium,	   the	   putP	   gene	   product	   serves	   as	   a	  major	  carrier,	   bringing	   L-­‐proline	   across	   the	   cytoplasmic	   membrane.	   Several	   proline	  transporters	  within	   the	  bacteria	   serve	   to	  bring	  proline	   into	   the	  bacterial	   cell.	  At	   least	  three	   proline	   transporters	   are	   able	   to	   transport	   proline	   into	   the	   bacterial	   cell;	   these	  include	  the	  low-­‐affinity	  ProP	  and	  ProU	  proteins	  as	  well	  as	  the	  high-­‐affinity	  PutP	  protein	  (Wood	  J	  M,	  1988;	  Jung	  H,	  2002).	  	  	  






Figure	  6.	  Secondary	  structure	  model	  of	  PutP	  of	  E.	  coli	  highlighting	  functional	  important	  residues.	  Gene	   fusion,	   cysteine	   accessibility,	   and	   EPR	   spectroscopic	   analyses	   of	   EcPutP	   suggest	   a	   secondary	  structure	   model	   according	   to	   which	   PutP	   contains	   13	   transmembrane	   domains	   (TMs)	   with	   the	   N	  terminus	   located	   on	   the	   periplasmic	   side	   of	   the	   membrane	   and	   the	   C	   terminus	   facing	   the	  cytoplasm.“Reprinted	   from	   FEBS	   Letters,	   Vol	   529/	   Issue	   1,	   Heinrich	   Jung,	   The	   sodium/substrate	  symporter	  family:structural	  and	  functional	  features,	  Pages	  No.	  73–77,	  Copyright	  (2002),	  with	  permission	  from	  Elsevier.”	  	  





(H2O2).	   The	   impact	   of	   Helicobacter	   PutA	   reactivity	   with	   oxygen	   was	   assessed	   by	  oxidative	  stress	  studies	   in	  an	  E.	  coli	  model	  system	  that	  demonstrated	  that	  the	  enzyme	  action	  of	  HpPutA	  is	  toxic	  to	  E.	  coli	  (Krishnan	  N	  	  and	  D	  F	  Becker,	  2006).	  	  There	  is	  also	  evidence	  that	  the	  bifunctional	  proline	  dehydrogenase	  HpPutA	  appears	  to	  be	   important	   for	   infection.	   A	   putA	  mutant	   did	   not	   display	   respiratory	   activity	   for	   L-­‐proline,	  had	  little	  motility	  and	  did	  not	  show	  swarming	  activity.	  Flagella	  seem	  to	  exist	  but	  full	   length	   sheathed	   flagella	   are	   rarely	   observed.	   Finally,	   the	   putA	   mutant	   proved	  incapable	  to	  colonize	  the	  stomach	  of	  mice	  (Nakajima	  K	  et	  al.,	  2008).	  	  
1.2.4	  Aim	  of	  this	  study	  	  Many	  organisms	  accumulate	  proline	  far	  in	  excess	  of	  the	  demands	  of	  protein	  synthesis	  to	  cope	  with	  environmental	  stress	  as	  well	  as	  an	  energy	  source.	  	  The	  conditions	  of	  the	  ecological	  niche	  of	  H.	  pylori	  are	  dominated	  by	  the	  gastric	  H+,	  K+-­‐ATPase,	   which	   secretes	   acid	   into	   the	   lumen	   of	   the	   stomach	   (Marais	   A	   et	   al.	   1999).	  Besides,	   the	   host	   inflammatory	   response	   can	   contribute	   to	   changes	   in	   the	  gastrointestinal	   environment	   trough	   the	  production	  of	   reactive	  oxygen	   species	   (ROS).	  Thus,	  H.	   pylori	   requires	   to	   cope	  with	   an	   onslaught	   of	   ROS	  during	   infection	   to	   survive	  (Alamuri	   P	   and	   R	   J	   Maier	   2004;	   Kelly	   D	   J,	   1998;	  Wang	   G	   and	   R	   J	   Maier,	   2004).	   The	  bacterium	  must	  have	  developed	  physiological	  strategies	  to	  survive	  in	  this	  environment.	  One	   of	   these	   strategies	   could	   be	   related	   to	   the	   proline	   metabolism	   because	   as	  mentioned	  before,	  in	  a	  genome	  wide	  search,	  the	  putative	  proline	  transporter	  in	  H.	  pylori	  



















































2.	  MATERIAL	  AND	  METHODS	  	  
2.1	  MATERIAL	  
	  
2.1.1	  Bacterial	  strains	  
Escherichia	   coli	   strains	   and	  Helicobacter	   pylori	   strains	   used	   in	   this	  work	   are	   listed	   in	  Table	  1.	  	  
Table	  1.	  Strains	  used	  in	  this	  study	  
Strain	   Genotype	  
E.	  coli	  DH5α	   F-­‐Φ80d	   lacZ	   ΔM15	   Δ(lacZYA-­‐argF)	   U169	   deoR	   recA1	   endA1	  
hsdR17	   (rK-­‐	   mK+)	   phoA	   supE44	   λ-­‐thi-­l	   gyr	   A96	   relA1	  (Invitrogen)	  (Hanahan,	  1983)	  
E.	  coli	  WG170	   (F_	   trp	   lacZ	   rpsL	   thi	   _(putPA)101	   proP219)	   (Stalmach	   et	   al.,	  1983)	  
E.	  coli	  WM3064	   (thrB1004	   pro	   thi	   rpsL	   hsdS	   lacZΔM15	   RP4-­‐1360	  Δ(araBAD)567	  ΔdapA1341::[erm	  pir])	  
Helicobacter	   pylori	  P12	   Clinique	   Isolate	   (888-­‐0)	   Division	   of	   „Medizinische	  Mikrobiologie	   und	   Immunologie“	   der	   Universität	   Hamburg	  (Schmitt	  et	  al.,	  1994)	  
	  	  
2.1.2	  Plasmids	  used	  in	  this	  study	  Plasmids	  used	  in	  this	  study	  are	  listed	  in	  Table	  2.	  	  
Table	  2.	  Plasmids	  used	  in	  this	  study	  
Plasmid	   Description	   Reference	  
pT7-­5	   AmpR,	  expression	  vector	  	   Tabor	   &	   Richardson,	  1990	  
pTMH6FH	   AmpR,	  putP-­‐	  wildtype	  in	  pt7-­‐5	   Jung,	  1998	  
pBluescript	  II	  SK+	   AmpR,	   oricolE1,	   orif1(+),	   lacZ,	   M13	  forward-­‐/	  reverse	   Stratagene	  
pTHpputP6H	   AmpR,	  HpputP-­‐	  wildtype	  in	  pt7-­‐5	   This	  work	  
pRHpputP6H	   AmpR,	  HpputP-­‐	  wildtype	  in	  pTrc99a	   This	  work	  
pBSK	   HpputP	  
rpsLerm	  
pBluescript	   II	   SK+	   harboring	   HpputP	   and	  the	  resistance	  cassette	  rpsLerm	   This	  work	  	  
pBSK	   HpputA	  
rpsLerm	  




pBluescript	   II	   SK+	   harboring	   the	  resistance	   cassette	   rpsLerm	   inserted	  between	   the	   flanking	   regions	   of	   	   HpputP	  and	  HpputA	  
This	  work	  	  
pBAD24	  GFP	  
	  
pBAD	  araC	  Ampr	   Guzman	  L	  M,	  et	  al.	  	  1995.	  	  




pIB6	   alpA	   Promotor-­‐Region	   in	   Shuttle-­‐Vector	  pHel3	  	   Barwig	  I,	  2009	  
pIB6	  alpA	  GFP	  
	  
Shuttle-­‐Vector	  pIB6	  harboring	  GFP	   This	  work	  
pIB6	  alpA	  HpputP	  
	  
Shuttle-­‐Vector	  pIB6	  harboring	  HpputP	   This	  work	  
pIB6	  alpA	  HpputP	  
GFP	  
Shuttle-­‐Vector	  pIB6	  harboring	  HpputP	  and	  
GFP	   This	  work	  
pIB6	   310HpputP	  
Promotor-­Region	  
HpputP	   Promotor-­‐Region	   replacing	   alpA	  promotor	  in	  Shuttle-­‐Vector	  pIB6	  	   This	  work	  
pIB6	   310HpputP	  
promotor	  GFP	  
HpputP	  Promotor-­‐Region	  in	  Shuttle-­‐Vector	  pIB6	  harboring	  GFP	   This	  work	  
pIB6	   310HpputP	  
promotor	  HpputP	  
HpputP	  Promotor-­‐Region	  in	  Shuttle-­‐Vector	  pIB6	  harboring	  HpputP	   This	  work	  
pIB6	   310HpputP	  
promotor	   HpputP	  
GFP	  
HpputP	  Promotor-­‐Region	  in	  Shuttle-­‐Vector	  pIB6	  harboring	  HpputP	  and	  GFP	   This	  work	  	  
pIB6	   500HpputP	  
Promotor-­Region	  
HpputP	   Promotor-­‐Region	   replacing	   alpA	  promotor	  in	  Shuttle-­‐Vector	  pIB6	   This	  work	  
pIB6	   500HpputP	  
promotor	  GFP	  
HpputP	  Promotor-­‐Region	  in	  Shuttle-­‐Vector	  pIB6	  harboring	  GFP	   This	  work	  
pIB6	   500HpputP	  
promotor	  HpputP	  
HpputP	  Promotor-­‐Region	  in	  Shuttle-­‐Vector	  pIB6	  harboring	  HpputP	   This	  work	  
pIB6	   500HpputP	  
promotor	   HpputP	  
GFP	  
HpputP	  Promotor-­‐Region	  in	  Shuttle-­‐Vector	  pIB6	  harboring	  HpputP	  and	  GFP	   This	  work	  	  	  	  
2.1.3	  Oligonucleotides	  used	  in	  this	  study	  Oligonucleotides	  were	  designed	  according	   to	   the	   standard	  parameters	  and	  ordered	  at	  Sigma-­‐Aldrich	  (Germany).	  The	  primers	  used	  are	  listed	  in	  Table	  3	  	  
Table	  3.	  Oligonucleotides	  used	  in	  this	  study	  	  
Name	   Sequence	  	  	  (5’	  to	  3’)	   Sequence	  amplified	  
HpputP_s	   AGGAGATCACCATGGGACATGTTG	   H.	  pylori	  putP	  
HpputP_as	   CTCATTTGAGCTCGAGGCATGCTTCAAGCTC	   H.	  pylori	  putP	  
HpputA_s	   AAAGGTAAGCATATGCAAAAAATC	   H.	  pylori	  putA	  
HpputA_as	   TTAATACAACTCGAGTTTTTCAGCACAG	   H.	  pylori	  putA	  
D58C	  sP	   GGAGCGAGCTGTATGAGCGGGTG	   HpPutP	  aa	  substitutions	  
D58C	  asP	   CCGCTCATACAGCTCGCTCCTGC	   HpPutP	  aa	  substitutions	  
S	  60C	  sP	   AGCGATATGTGCGGGTGGCTTTTA	   HpPutP	  aa	  substitutions	  
S60C	  asP	   AAGCCACCCGCACATATCGCTCGC	  	   HpPutP	  aa	  substitutions	  
Y143C	  sP	   TTTATTTTTTGCATTTCTTCAGGG	  	   HpPutP	  aa	  substitutions	  
Y143C	  asP	   TGAAGAAATGCAAAAAATAAAAAA	  	   HpPutP	  aa	  substitutions	  
W247C	  sP	   GGGATTTCTTGTATGGTTATTTCT	  	   HpPutP	  aa	  substitutions	  
W247C	  asP	   AATAACCATACAAGAAATCCCAAT	  	   HpPutP	  aa	  substitutions	  
E311C	  sP	   GAAGACCCTTGTAAGATTTTCATT	  	   HpPutP	  aa	  substitutions	  




E311C	  asP	   GAAAATCTTACAAGGGTCTTCTAA	  	   HpPutP	  aa	  substitutions	  
S339C	  sP	   GCGGTGATGTGCACGGCCAGTTCG	  	   HpPutP	  aa	  substitutions	  
S339C	  asP	   ACTGGCCGTGCACATCACCGCCGC	  	   HpPutP	  aa	  substitutions	  
T340C	  sP	   GTGATGAGCTGCGCCAGTTCGCAA	  	   HpPutP	  aa	  substitutions	  
T340C	  asP	   CGAACTGGCCGTGCACATCACCGC	  	   HpPutP	  aa	  substitutions	  
DelputP_A_s	   CTATCATCTAAGCTTTGGATCGTGTTTTG	   H.	  pylori	  deletion	  mutants	  
DelputP_A_as	   CCACAAGTCAGGATCCGCTGAAAAATAA	   H.	  pylori	  deletion	  mutants	  
DelputP_B_s	   AACAATAGGGGATCCTAAAACAACATG	   H.	  pylori	  deletion	  mutants	  
DelputP_B_as	   GCGATTTCAGCGGCCGCACTGAGCTTTTTAC	   H.	  pylori	  deletion	  mutants	  
DelputA_A_s	   GGGTCTTCTAAGCTTAAGTCAAATTTA	   H.	  pylori	  deletion	  mutants	  
DelputA_A_as	   CCACAAGTCAGGATCCGCTGAAAAATAA	   H.	  pylori	  deletion	  mutants	  
DelputA_B_s	   TGAATCGTCGGATCCTTTTTGCATGAG	   H.	  pylori	  deletion	  mutants	  
DelputA_B_as	   TTATCTTTTGCGGCCGCTAGAGCGGTGTT	   H.	  pylori	  deletion	  mutants	  
HpputPKP1	   ATTCTTGTAATTCTAAATC	   H.	  pylori	  deletion	  mutants	  
HpputPKP2	   AAAATTACGAAATCCCGGC	   H.	  pylori	  deletion	  mutants	  
HpputAKP3	   CGCCGCTAAAATCGCGCTC	   H.	  pylori	  deletion	  mutants	  
HpputAKP4	   TGCTGAGATTGTTCTAACG	   H.	  pylori	  deletion	  mutants	  
DelputP_A_asne
u	   CTTAAAGAAGGATCCAGCTTGAAGCATTAAG	   H.	  pylori	  deletion	  mutants	  
Erm	  s	   CATAAGTACGGATATAATACG	   rpsLErm	  cassette	  
Erm	  as	   CGTATTATATCCGTACTTATG	   rpsLErm	  cassette	  
rpsL	  s	   TTTGAAGTGATCAGCTATATC	   rpsLErm	  cassette	  
rpsL	  as	   ATAGCTGATCACTTCAAAGCC	   rpsLErm	  cassette	  
Subst	  Primer	  29	  	  
GAAATCCCAATAGTGGTCGCTTTAGGCACATCTCT	   H.	  pylori	  deletion	  mutants	  
HpPutP	  
pIB6compl_s	  	   CAGGAAAGGACATATGGGACATGTTGTTTTAAG	   H.	  pylori	  complem	  mutants	  
HpPutP	  
pIB6compl_as	  
GCTTATCATGCGGCCGCTTAGTGGTGGTGG	  	   H.	  pylori	  complem	  mutants	  
PutAs	   GAGAAAGAAGAGGCGATTTAGTAGGGATTTCGG	   H.	  pylori	  complem	  mutants	  
PutAas	   AAGTCAATGGCTTCGCTCACTTCAGCGTCCGT	   H.	  pylori	  complem	  mutants	  
HpPutP	  NdeI_s	  
AAGGAAAGGACATATGGGACATGTTGTTTTAAGCACCCCTATT	   H.	  pylori	  complem	  mutants	  
HpPutP	  NotI_as	  
GCTTATCATGCGGCCGCTTAGTGGTGGTGGTGGTGGTGGCTC	   H.	  pylori	  complem	  mutants	  
putAF_Not_as	  
TTGTTAGCAGCGGCCGCTCACTTGTCATCGTCGTCCTTGTAGTCTTTTTCAGCACAGCATGAC	   H.	  pylori	  complem	  mutants	  
putA_Not_as	  
TTGTTAGCAGCGGCCGCTCATTTTTCAGCACAGCATGAC	   H.	  pylori	  complem	  mutants	  
gfpNde_s	   GAGGAATTCCATATGGTACCAAG	   H.	  pylori	  complem	  mutants	  
gfpNot_as	   CCAAAACAGGCGGCCGCTTATTTGTATAG	   H.	  pylori	  complem	  mutants	  
gfpXho_s	   GAGGCCTCGAGCATGGTACCAAG	   H.	  pylori	  complem	  mutants	  
gfpXho_as	   AAAACAGCCGCTCGAGGCTTTGTATAGTTC	   H.	  pylori	  complem	  mutants	  
era-­F	  	   AAGGCTAATGCGACCAGAAA	   H.	  pylori	  constitutive	  gene	  
era-­R	  	   GGAGCCCTGGTGTGTCTAAA	  	   H.	  pylori	  constitutive	  gene	  
flaA-­F	  	   CATGGGGATTATCCAAGTTG	  	   H.	  pylori	  flagella	  genes	  




flaA-­R	  	   CGATACGAACCTGACCGATT	   H.	  pylori	  flagella	  genes	  
flgE-­F	  	   GGCTAACGACCGAAATTACG	   H.	  pylori	  flagella	  genes	  
flgE-­R	  	   TGAAATTCCCCCTCGCTTGG	   H.	  pylori	  flagella	  genes	  
flaB-­F	  	   ACCAGAACCGACGCTAGAGA	   H.	  pylori	  flagella	  genes	  
flaB-­R	  	   CCACATTCGCATCAAAAATG	   H.	  pylori	  flagella	  genes	  
flgM-­F	  	   AGTGAGACCGCTCTTGATAG	   H.	  pylori	  flagella	  genes	  
flgM-­R	  	   CCCAATAAATCCTGTGCCATT	   H.	  pylori	  flagella	  genes	  
flhA-­F	  	   CACCATTCCTGGACTCCCTA	  	   H.	  pylori	  flagella	  genes	  
flhA-­R	  	  	   TTAGTGAGCAACCCGTCTTT	   H.	  pylori	  flagella	  genes	  
flhF-­F	  	   ATTAAGCCTGGAATTAATGC	   H.	  pylori	  flagella	  genes	  
flhF-­R	  	   TTAGTGAGCAACCCGTCTTT	   H.	  pylori	  flagella	  genes	  
rpoN-­F	  	   TGGCATTGGCGCTAAAGATG	   H.	  pylori	  flagella	  genes	  
rpoN-­R	  	   CGCGCTTCTTCATAAAGCTCA	   H.	  pylori	  flagella	  genes	  
fliA-­F	  	   GAATGCCCAAAGGAATTCAA	  	   H.	  pylori	  flagella	  genes	  
fliA-­R	  	   AGCGAGATCGTCTTGATGGT	   H.	  pylori	  flagella	  genes	  
ProU_s	   TGCTCGCTATCCCCCAAATTTTAGT	   H.	  pylori	  ProU	  
Pro	  U_as	   AAAAATCGCCTGCCCTAAGC	   H.	  pylori	  ProU	  
ProP_s	   CTGTAGTTTCTGGGATTTTG	   H.	  pylori	  ProP	  
ProP_as	   CCTCAAATAGACAGAAATGA	   H.	  pylori	  ProP	  
RTHpPutP_s	   TTCAGGGCTGGTGAGTGGGGCTAA	   H.	  pylori	  PutP	  
RTHpPutP_as	   AATCCGTCCAGCACACCGCCTT	   H.	  pylori	  PutP	  
FlgE_s2	   GGCTGGTTTGTGATAGGGCC	   H.	  pylori	  flagella	  genes	  
FlgE_as2	   AATTACCGGCGCGGGTTAGA	   H.	  pylori	  flagella	  genes	  
FlhF_s2	   ATGAAATCGTTGTGGCGGTT	   H.	  pylori	  flagella	  genes	  
FlhF_s2	   GACCACATCTTCTTCATTCAATTCT	   H.	  pylori	  flagella	  genes	  	  	  
2.1.4	  Antibodies	  	  The	  antibodies	  used	  in	  this	  study	  are	  listed	  in	  Table	  4.	  	  
Table	  4.	  Antibodies	  used	  in	  this	  study	  	  
Antibodies	   Company	  Penta	  His	  HRP-­‐conjugate	  mouse	  antibody	   Qiagen	  Monoclonal	   Anti-­‐Green	   Fluorescent	  Protein	  (GFP)	  antibody	   Qiagen	  
	  
	  
2.1.5	  Antibiotics	  The	  antibiotics	  used	  in	  this	  study	  are	  listed	  in	  Table	  5.	  	  
Table	  5.	  Antibiotics	  used	  for	  selective	  plates	  and	  medium	  	  
Antibiotic	   Abreviation	   Disolved	  in	   Final	  concentration	  in	  
medium	  Ampicillin	   Amp	   H2O	   100	  mg/l	  (LB-­‐Medium/-­‐Plates)	  Diaminopimelic	  acid	   DAP	   H2O	   14	  mg/l	  (LB-­‐Plates)	  




Kanamycin	   Kan	   H2O	   50	  mg/l	  (LB-­‐Medium/-­‐Plates)	  	  8	  mg/l	  (Serumplates)	  	  Erythromycin	   Erm	   EtOH	   250	  mg/l	  (E.	  coli)	  10	  mg/l	  (H.	  pylori)	  Nystatin	   Nys	   H2O	   440	  ml/l	  (H.	  pylori)	  Streptomycin	   Strep	   H2O	   250	  mg/l	  Trimetoprim	   	   H2O	   5	  mg/	  l	  Vancomycin	   Van	   H2O	   10	  mg/l	  	  	  
2.1.6	  Culture	  medium	  	  Culture	  media	  used	  for	  this	  study	  is	  listed	  in	  Table	  6	  
	  
Table	  6.	  Culture	  media	  for	  E.	  coli	  or	  H.	  pylori	  respectively	  	  
Bacteria	   Solution	   Recipe	  Liquid	  culture	   Luria	   Bertani-­‐Medium	   (Miller,	   1992).	   1%	   (w/v)	  bacto	   triptone,	   0.5%	   yeast	   extract	   and	   1%	   (w/v)	  sodium	  chloride.	  Autoclaved	  Agar	  plates	   1.5%	   agar-­‐agar	   was	   added	   to	   the	   LB-­‐medium	   and	  autoclaved	  
For	  E.	  coli	  	  
Glycerol	  medium	  	   LB-­‐medium,	  20%	  glycerin	  (v/v)	  Serum	  plates	   36	   g/l	   GC-­‐Agar-­‐Base	   (oxoid),	   autoclaved,	   10	   ml/l	  vitaminmix,	   80	   ml/l	   horse	   serum,	   10	   mg/l	  vancomycin,	  1	  mg/l	  nystatin,	  5	  mg/l	  trimethoprim	  Vitamin	  mix	   100	   g/l	   α-­‐D-­‐glucose,	   10	   g/l	   L-­‐glutamine,	   26	   g/l	   L-­‐cysteine,	   0.1	   g/l	   cocarboxylase,	   20	   mg/l	   Fe(III)-­‐nitrate,	   3	   mg/l	   thiamin,	   13	   mg/l	   p-­aminobenzoic	  acid,	   0.25	   g/l	  NAD,	   10	  mg/l	   vitamin	  B12,	   1.1	   g/l	   L-­‐cystine,	   1	   g/l	   adenine,	   30	  mg/l	   guanine,	   0.15	   g/l	   L-­‐arginine,	  0.5	  g/l	  uracil,	  sterilized	  by	  filtration	  Brucella-­‐Medium	   28	   g/l	   Brucella-­‐Broth	   (BD),	   autoclaved	  supplemented	  with	  80	  ml/l	  horse	  serum	  Glycerol	  medium	  	   Brucella-­‐medium,	  20%	  glycerin,	  10%	  FCS	  	  RPMI	   1640	  Medium	   (Gibco)	  
For	  H.	  pylori	  	  
Defined	  Medium	   RPMI	   1640	   medium,	   suplemented	   with	   100	   mg/l	  	  Ca(NO3)2•4H2O,	  	  400	  mg/l	  	  KC1,	  100	  mg/l	  	  SO4	  .7H2O,	  6000	   mg/l	   	   NaCl,	   800	   mg/l	   	   Na2HPO4,	   2000	   mg/l	  	  NaHCO3	   2000	   mg/l	   	   Glucose,	   5000	   mg/l	   	   Bovine	  serum	  albumin,	  5	  mg/l	  	  Phenol	  red	  (optional),	  2	  mg/l	  	  FeSO,	  50	  mg/l	  	  Adenine,	  3	  mg/l	  	  Lipoic	  acid,	  0.2	  mg/l	  	  D-­‐Biotin,	  3	  mg/l	  	  Choline	  chloride,	  1	  mg/l	  	  Folic	  acid,	  35	  mg/l	  	  my-­‐Inositol,	  1	  mg/l	  	  Niacinamide,	  1	  mg/l	  	  p-­‐Aminobenzoic	  acid,	  1.25	  mg/l	  	  D-­‐Pantothenic	  acid,	  1	  mg/l	  	  Pyridoxine	  hydrochloride,	  0.2	  mg/l	  	  Riboflavin,	  1	  mg/l	  	  Thiamin	  hydrochloride,	  0.005	  mg/l	  	  Vitamin	  B12,	   44.5	   mg/l	   	   Alanine	   hydrochloride,	   632	   mg/l	  	  




	   Arginine,	   75	  mg/l	   	   Asparagine,	   66.5	  mg/l	   	   Aspartic	  acid,	   120	   mg/l	   	   Cystine,	   73.5	   mg/l	   	   Glutamic	   acid,	  300	  mg/l	   	  Glutamine,	  37.	  5	  mg/l	   	  Glycine,	  110	  mg/l	  	  Histidine,	  262.5	  mg/l	  	  Isoleucine,	  262	  mg/l	  	  Leucine,	  362.5	  mg/l	  	  Lysine,	  75.5	  mg/l	  	  Me	  thionine,	  165	  mg/l	  	  Phen	  ylalanine,	  57.5	  mg/l	  	  Proline,	  52.5	  mg/l	  	  Serine,	  238	  mg/l	  	  Threonine,	  51	  mg/l	  	  Tryptophan	  	  	  
2.1.7	  Buffers	  and	  solutions	  	  
2.1.7.1	  Buffers	  for	  transformation	  of	  competent	  cells	  in	  E.	  coli	  Buffers	  used	  for	  transformation	  of	  competent	  cells	  in	  E.	  coli	  are	  listed	  in	  Table	  7	  
	  
Table	  7.	  Buffers	  for	  transformation	  of	  competent	  cells	  in	  E.	  coli	  
Buffer	   Recipe	  Buffer	  I	   10mM	  MOPS,	  10	  mM	  RbCl,	  pH	  7,	  sterilized	  by	  filtration	  Buffer	  II	   10	   mM	  MOPS,	   10	   mM	   RbCl,	   50	   mM	   CaCl2,	   pH	   6.5	   adjusted	   with	  KOH,	  sterilized	  by	  filtration	  	  	  
2.1.7.2	  Buffers	  for	  gel	  electrophoresis	  Buffers	  used	  for	  gel	  electrophoresis	  are	  listed	  in	  Table	  8	  
	  
Table	  8.	  Buffers	  for	  gel	  electrophoresis	  
Buffer	   Recipe	  TAE-­‐Buffer	   40mM	  Tris,	  40mM	  acetic	  acid,	  1mM	  EDTA	  Loading	  Buffer	   50%	   (v/v)	   glycerin,	   0.1M	   EDTA,	   1	   %	   (w/v)	   SDS,	   0.2%	  Bromophenol	  blue	  dye	  
	  
	  
2.1.7.3	  Buffers	  and	  solutions	  for	  membrane	  preparation	  	  Buffers	  for	  membrane	  preparation	  used	  for	  this	  study	  are	  listed	  in	  Table	  9	  	  
Table	  9.	  Buffers	  and	  solutions	  for	  membrane	  preparation	  	  
Bacteria	   Buffer	   Recipe	  For	  E.	  coli	  
	  
Kpi	  Buffer	   1M	  stock	  solutions	  of	  K2HPO4	  and	  KH2PO4	  were	  prepared	  and	  the	  corresponding	  amounts	  of	  each	  one	  were	  used	  to	  prepare	  the	  buffer	  at	  the	  desired	  pH	  0.5L	  of	  1M	  K2HPO4	  at	  174.18g	  mol-­‐1	  =	  87.09g	  0.5L	  of	  1M	  KH2PO4	  at	  136.09g	  mol-­‐1	  =	  68.045g	  For	  H.	  Pylori	  
	  











2.1.7.4	  Buffers	  and	  solutions	  for	  SDS-­Polyacrylamidgel-­electrophoresis	  	  Buffers	  used	  for	  SDS-­‐Polyacrylamidgel-­‐electrophoresis	  are	  listed	  in	  Table	  10	  	  
Table	  10.	  Buffers	  and	  solutions	  for	  SDS-­Polyacrylamidgel-­electrophoresis	  
Buffer	   Recipe	  Spacer	  buffer	   0.4%	  SDS,	  0.5M	  Tris/HCl	  pH	  6.76,	  10%	  APS,	  0.1%	  TEMED	  Stacking	  buffer	   0.4%	   SDS	   (w/v),	   1.5M	   Tris/HCl	   pH	   8.8,	   10%	   APS,	   0.1%	  TEMED	  Electrophoresis	  Buffer	   25	  mM	  Tris-­‐HCl,	  250	  mM	  glycine,	  0.1%	  (w/v)	  SDS,	  pH	  8,3	  Coomassie-­‐Solution	   0.275%	  Coomassie	  Brilliant	  Blue	  R250	  (w/v),	  50%	  Methanol	  (v/v),	  10%	  acetic	  acid	  (v/v).	  Destaining	  solution	   	   10%	   Methanol	   (v/v),	   10%	   Ethanol	   (v/v),	   7.5%	   Acetic	   acid	  (v/v).	  
	  
	  
2.1.7.5	  Buffers	  and	  solutions	  for	  Western-­Blot	  	  Buffers	  and	  solutions	  for	  Western-­‐Blot	  used	  in	  this	  study	  are	  listed	  in	  Table	  11	  
	  
Table	  11.	  Buffers	  and	  solutions	  for	  Western-­Blot	  	  
Buffer	   Recipe	  Transfer	  Buffer	   15.6mM	   Tris,	   120mM	   glycine,	   20%	   (v/v)	   methanol,	  0.02%	  (w/v)	  SDS	  Tris-­‐buffered	   saline	  (abbreviated	  TBS).	   150	  mM	  NaCl,	  20	  mM	  Tris-­‐HCl,	  pH	  7.5	  TBS-­‐T	  	  	   TBS,	  0.5	  %	  Tween	  20	  (v/v)	  TBS-­‐TT-­‐	  Buffer	   TBS-­‐T-­‐Buffer	  with	  0.1%	  (v/v)	  Tween	  Blocking	  Buffer	   TBS,	  3%	  BSA	  (w/v)	  	  	   	   	  	  
2.1.7.6	  Buffers	  and	  solutions	  for	  protein	  quantification	  For	   protein	   quantification,	   the	   methods	   of	   Peterson	   or	   Bradford	   were	   used	   and	   the	  reagents	  used	  for	  each	  one	  are	  listed	  below	  	  For	  Peterson	  Solution	  A	   	   	   CTC:	  0.8N	  NaOH:	  10%	  SDS	  	  	  CTC:	  Copper	  tartrate/carbonate	  (CTC)	  solution	  	  0.22%	  KNa-­‐tartrate	  4H2O	  0.1%	  CuSO4	  5H2O	  Dissolve	  in	  10%	  Na2CO3	  	  Folin–Ciocalteu	  reagent	  (FCR):	  H2Odest	  (1:5)	  	  For	  Bradford	  	  	  Bradford	  Reagent	   Serva	  Blue	  G-­‐250	  (0.07g),	  ethanol	  96%	  (50ml),	  H3PO4	  85%	  (100ml),	  H2O	  (to	  1L).	  	  




Standard	  curve	  was	  made	  from	  0	  to	  5µg	  protein.	  20	  µl	  of	  the	  sample	  were	  mixed	  with	  1	  ml	   of	   the	   reagent,	   incubated	   for	  5min	   at	   room	   temperature	   and	  OD	  was	  measured	   at	  578nm	  	  	  
2.1.7.7	  Buffers	  for	  transport	  measurements	  in	  proteoliposomes	  Buffers	  used	  for	  transport	  measurements	  in	  proteoliposomes	  are	  listed	  in	  Table	  12	  
	  
Table	  12.	  Buffers	  for	  transport	  measurements	  in	  proteoliposomes	  
Buffer	   Recipe	  Buffer	  1	   100	  mM	  KPi,	  5	  mM	  MgCl2,	  2	  mM	  ß-­‐	  Mercaptoethanol	  	  Buffer	  2	  (∆µNa+)	   100	   mM	   Tris/	   Mes	   pH	   7.5,	   5	   mM	   MgCl2,	   2	   mM	   ß-­‐	  Mercaptoethanol,	  50	  mM	  NaCl	  Buffer	  3	  (∆µLi+)	  	  	   100	  mM	   Tris/	  Mes	   pH	   7.5	   (Na+-­‐	   free),	   5	  mM	  MgCl2,	   2	  mM	   ß-­‐	  Mercaptoethanol,	  50	  mM	  LiCl	  Buffer	  4	  (∆µH+)	   100	  mM	   Tris/	  Mes	   pH	   6.0	   (Na+-­‐	   free),	   5	  mM	  MgCl2,	   2	  mM	   ß-­‐	  Mercaptoethanol	  Buffer	  5	  (∆µNa+,	  pH)	   100	   mM	   Tris/	   Mes	   pH	   6.0,	   5	   mM	   MgCl2,	   2	   mM	   ß-­‐	  Mercaptoethanol,	  50	  mM	  NaCl,	  2	  mM).	  	  	  
2.1.7.8	  Buffers	  and	  solutions	  for	  Transport	  measurements	  in	  E.	  coli	  and	  H.	  pylori	  Buffers	  used	  for	  transport	  measurements	  in	  E.	  coli	  of	  H.	  pylori	  are	  listed	  in	  Table	  13	  
	  
Table	  13.	  Buffers	  and	  solutions	  for	  Transport	  measurements	  in	  E.	  coli	  and	  H.	  pylori	  
Bacteria	   Buffer	   Recipe	  Transport	  Buffer	   100mM	  Tris/Mes	  BufferpH	  6.0	  E.	  coli	   Stop	  Buffer	   100mM	  LiCl,	  100mMKH2PO4	  Transport	  Buffer	   100mM	  Tris/Mes	  Buffer,	  150mM	  KCl	  pH	  7.0	  H.	  pylori	   Stop	  Buffer	   100mM	  LiCl,	  100mMKH2PO4	  
	  	  
2.1.8	  Enzymes	  and	  Proteins	  used	  in	  this	  study	  Enzymes	  and	  Proteins	  used	  in	  this	  study	  are	  listed	  in	  Table	  14.	  	  
Table	  14.	  Enzymes	  and	  Proteins	  used	  in	  this	  study	  
Enzyme	   Company	  Alkaline	   Phospathase	   (AP)-­‐gekoppeltes	  Protein	  A	  Sigma	  DNaseI	   Fermentas	  	  








2.1.9	  Molecular	  markers	  Molecular	  markers	  used	  in	  this	  study	  are	  listed	  in	  table	  15	  	  
Table	  15.	  Molecular	  markers	  
Molecular	  marker	   Company	  DNA-­‐Gelelectrophoresis	  2	  log	  DNA	  Ladder	   New	  England	  Biolabs	  Polyacrylamid-­‐Gelelectrophoresis	  PageRulerTM	   Prestained	   Protein	   Ladder	  standard	   Fermentas	  	  	  
2.1.10	  Chemicals	  and	  Reagents	  	  Acrylamid/Methylenbisacrylamid	   29:1	   (30%)	   (Roth),	   NNN’N’Tetramethylendiamid	  (TEMED)	  (Merk),	  Tween20	  (Serva),	  Desoxyribonukleinsäure-­‐Triphosphat	  Mix	  (dNTPs)	  (Roche),	   Alkaline	   Phosphatase	   Calf	   Intestinal	   (CIP)	   (NEB),	   DMSO	   (Sigma),	   EDTA	  (Sigma),	  Ethidiumbromid	  (Sigma),	  Agarose	  (Serva),	   	  Ampicillin	  (Sigma),	  Trimethoprim	  (Sigma),	   Trypan	   Blue	   (Invitrogen),	   Vancomycin	   (Sigma),	   Erythromycin	   (Roth),	  Vancomycin	   (Sigma),	   Nystatin	   (Sigma),	   Trimethroprim	   (Sigma),	   Kanamycin	   sulfat	  (Roth),	   MES	   (Roth),	   Carbenicillin	   (Roth),	   L-­‐hydroxyproline	   (Applichem),	   Tryptone	  (Roth),	   Agar-­‐agar	   (BD	   Difco),	   Bacto	   yeast	   extract	   (BD),	   Sodium	   Chloride	   (Prolabo),	  Brucella-­‐Broth	   Medium	   (Becton	   Dickinson),	   GC-­‐Agar	   (Oxoid),	   Horse	   serum	   (PAA	  laboratories	   GmbH),	   Glycerin	   (Roth),	   PMSF	   (Sigma),	   Poly-­‐L-­‐Lysin	   (Sigma),	   IPTG	  (AppliChem),	   ATP	   (Roche),	   Bromphenolblau	   (ServaDAP	   (Sigma),	   E.	   coli	   polar	   lipid	  extract	   in	   Chloroform	   (acetone/ether	   purified,	   Avanti	   Cat.#	   100600),	   Incidine	   Plus	  (Ecolab)	  	  	  
2.1.11	  Commercial-­Kits	  	  Commercial	  kits	  used	  in	  this	  study	  are	  listed	  in	  Table16	  
	  
Table	  16.	  Commercial-­Kits	  	  
Use	   Kit	   Company	  RNA	  extraction	   Quick-­‐RNATM	  MicroPrep	   ZyMo	  research	  DNA	  extraction	   ReliaPrep	   gDNA	   Tissues	   Miniprep	  system	   Promega	  Retrotranscription	   RT	  Kit	  Thermo	  Scientific	  RevertAid	  First	  Strand	  cDNA	  synthesis	  kit	   Thermo	  Scientific	  Plasmid	  purification	   HiYield	  Plasmid	  Mini	  DNA-­‐kit	  	   SLG®	  DNA	  gel-­‐extraction	   HiYield	  PCR	  Clean-­‐up/Gel	  extraction-­‐kit	   SLG®	  
	  	   	   	  










2.2.1	  Bacteria	  cultures	  	  	  
2.2.1.1	  Cultures	  of	  Escherichia	  coli	  	  
E.	  coli	  strains	  were	  grown	  on	  Luria-­‐Bertani	  agar	  (LB)-­‐Plates	  (Miller	  J	  H,	  1992)	  or	  in	  LB-­‐liquid	  medium	  at	  37°C.	  For	  the	  selection	  of	  plasmids	  in	  E.	  coli,	  media	  was	  supplemented	  with	   erythromycin	   (10mg/l),	   ampicillin	   (100	  mg/l),	   or	   kanamycin	   (50	  mg/l).	   For	   the	  strain	   collection	   the	   cell	   material	   was	   taken	   from	   an	   overnight	   liquid	   culture	   with	  glycerin	   (3:1)	   and	   stored	   at	   -­‐70°C.	   Recombinant	   plasmids	   were	   transformed	   and	  maintained	  in	  E.	  coli	  DH5α	  (Bethesda	  Research	  Laboratories).	  	  	  	  
2.2.1.2	  Cultures	  of	  Helicobacter	  pylori	  	  
H.	  pylori	  strains	  were	  cultured	  on	  GC	  agar	  serumplates	  or	  brucella	  broth	  (BB)	  for	  liquid	  cultures	   supplemented	   with	   10%	   horse	   serum	   (HS)	   and	   the	   following	   antibiotics:	  vancomycin	   (10	   mg/l),	   nystatin	   (1mg/l),	   trimethoprim	   (5	   mg/l).	   Cultures	   were	  incubated	  at	  37°C	  under	  microaerobic	  conditions	  (85%	  N2.	  10%	  CO2.	  5%	  02)	  (Barwig	  I,	  2009).	  When	  necessary	  for	  selection	  of	  H.	  pylori	  allelic	  exchange	  mutants,	  erythromycin	  (10mg/l)	  or	  streptomycin	  (10mg/l)	  was	  used	  in	  addition	  to	  the	  other	  antibiotics.	   	   	  For	  the	  strain	  collection	  the	  cells	  from	  one	  plate	  were	  resuspended	  in	  1	  ml	  brucella-­‐medium	  with	  20%	  glycerin	  and	  10%	  HS	  and	  stored	  at	  -­‐70°C.	  	  	  
2.2.1.3	  Growth	  studies	  Growth	  over	  time	  was	  assessed	  by	  measurement	  of	  OD600.	  Liquid	  cultures	  were	  grown	  in	  15	  ml	  volumes	  of	  medium	  in	  100	  ml	  conical	  flasks	  with	  gentle	  shaking	  (100	  r.p.m.)	  or	  in	  1	  ml	  volumes	  in	  the	  wells	  of	  a	  24-­‐well	  tray	  (NUNC)	  with	  gentle	  shaking	  (100	  r.p.m.)	  (Reynolds	  D	   J	  and	  Penn	  C	  W,	  1994).	   	   Inocula	  were	  grown	  for	  48h	  on	  agar	  plates	   then	  suspended	  in	  Brucella	  Broth	  media,	  and	  standardized	  to	  1	  x	  l08	  cells/ml	  (OD600	  of	  0.2).	  Inoculation	   was	   carried	   out	   in	   a	   laminar-­‐flow	   hood	   and	   the	   cultures	   immediately	  transferred	  to	  the	  Jar	  with	  the	  gas	  mixture	  and	  shaken	  at	  37	  °C.	  For	  	  studies	  in	  defined	  medium,	  liquid	  cultures	  were	  grown	  in	  1	  ml	  volumes	  in	  the	  wells	  of	  a	  24-­‐well	  tray	  (NUNC)	  with	  gentle	  shaking	  (100	  r.p.m.).	  	  Inocula	  were	  grown	  for	  48h	  on	  agar	  plates	  then	  suspended	  in	  RPMI	  media,	  with	  or	  without	  addition	  of	  the	  mixture	  of	  amino	  acids,	  vitamins	  and	  BSA	  as	  listed	  in	  Table	  6.	  Cells	  were	  standardized	  to	  1	  x	  l08	  cells/ml	   (OD600	   of	   0.2).	   Inoculation	   was	   carried	   out	   in	   a	   laminar-­‐flow	   hood	   and	   the	  cultures	  immediately	  transferred	  to	  the	  Jar	  with	  the	  gas	  mixture	  and	  shaken	  at	  37	  °C.	  	  	  
2.2.1.4	  Motility	  assay	  (soft	  agar	  plates).	  	  









2.2.1.5	  Transformation	  of	  E.	  coli	  	  	  Chemically	  competent	  cells;	  Rubidium	  Chloride	  Method.	  	  A	   single	   colony	   from	  E.	   coli	  was	   used	   to	   inoculate	   5ml	   of	   LB	  medium	   and	   incubated	  overnight	  at	  37°C	  with	  vigorous	  shaking.	  100µl	  from	  this	  overnight	  culture	  was	  used	  to	  prepare	  a	  new	  10ml	  culture	  which	  was	  incubated	  2	  h	  at	  37°C	  until	  an	  OD600	  of	  0.3-­‐0.5	  was	   reached.	   Cells	   were	   harvest	   by	   centrifugation	   5	   min	   at	   5000rpm	   4°C	   and	  resuspended	  in	  5ml	  of	  Buffer	  I,	  washed	  again	  and	  respuspended	  in	  5ml	  Buffer	  II.	  Cells	  were	   incubated	   30	   min	   on	   ice,	   centrifuged	   (5	   min	   at	   5000rpm	   4°C)	   and	   finally	  resuspended	  in	  1ml	  Buffer	  II.	  Heatshock-­‐Transformation	  of	  E.	  coli	  cells	  For	  transformation,	  200	  µl	  of	  competent	  cells	  were	  inoculated	  with	  1	  µl	  of	  Plasmid-­‐DNA	  and	   incubated	   for	  30	  min	  at	  4°C.	  A	   thermal	   shock	  was	  applied	   for	  20	  sec	  at	  37°C	  and	  then	  incubated	  2-­‐3	  min	  on	  ice.	  800	  µl	  LB	  medium	  was	  added	  followed	  by	  incubation	  for	  45	  min	  37	  °C	  and	  750	  rpm.	  At	  the	  end,	  100	  µl	  aliquots	  of	  the	  cell	  suspension	  was	  spread	  on	  LB	  selective-­‐plates	  and	  incubated	  at	  37°C	  overnight	  	  	  
2.2.1.6	  Transformation	  of	  H.	  pylori	  Natural	  transformation	  of	  H.	  pylori	  strains	  was	  performed	  with	  plasmid-­‐DNA	  according	  to	   the	   procedure	   described	   by	  Haas	   et	   al.	   1993.	  H.	   pylori	  was	   grown	   for	   2-­‐3	   days	   on	  serum	   plates	   and	   harvested	   in	   1mL	   BB	   containing	   10%	   HS.	   The	   suspension	   was	  adjusted	  to	  an	  OD600	  of	  0.2	  in	  a	  24-­‐well	  tissue	  culture	  plate	  (approx	  3x107	  bacteria	  mL-­‐1)	  and	   1-­‐3µg	   of	   supercoiled	   plasmid	   or	   chromosomal	   DNA	  was	   added.	   The	   culture	  was	  incubated	  a	  minimum	  of	  4h	   (5%	  CO2	  37°C).	  Cells	  were	  harvested	  by	  centrifugation	  at	  3500rpm	   for	   5	   min	   and	   spread	   on	   serum	   selective	   plates.	   Afterwards	   plates	   were	  incubated	   for	   4-­‐5	   days	   under	  microaerobic	   conditions	   (85%	  N2,	   10%	   CO2,	   5%	  O2)	   at	  37°C.	   Resulting	   colonies	   were	   amplified	   and	   DNA	   was	   isolated	   to	   verify	   the	   right	  insertion	  (Haas	  R,	  et	  al.,	  1993).	  	  	  
2.2.1.7	  Conjugation	  of	  H.	  pylori	  	  Natural	   transformation	   of	   H.	   pylori	   has	   shown	   lower	   transformation	   efficiency	   for	  shuttle	   vectors	   (Heuermann	   D	   and	   Haas	   R.	   1998)	   due	   to	   DNA	   restriction	   and	   strain	  specific	   modification	   mechanisms.	   For	   the	   complementation	   of	   the	   deletion	   mutants	  with	   the	   shuttle	   vector	  pIB6,	   conjugation	  was	  used	   instead	  of	   transformation,	   as	  DNA	  restriction	  seems	  to	  be	  strongly	  reduced	  or	  absent	  during	  conjugal	  transfer.	  
E.	  coli	  WM3064	  was	  transformed	  with	  the	  plasmid	  of	  interest	  by	  the	  rubidium	  chloride	  method	  already	  mentioned	  above.	  Overnight	   cultures	  of	   the	  donor	   (E.	   coli	  WM3064	   +	  plasmid+	  DAP+	  selective	  antibiotic)	  and	  recipient	  strains	  (H.	  pylori	  ΔHpPutP,	  ΔHpPutA	  
and	  ΔHpPutAP)	  were	  grown.	  100µl	  of	  the	  donor	  strain	  and	  300µl	  of	  the	  recipient	  strain	  were	  spin	  down,	  washed	  once	  with	  medium	  and	  resuspended	  in	  100	  µl	  of	  BB.	  The	  entire	  volume	   of	   cells	   (100µl	   of	   each	   strain)	   was	   added	   to	   a	   serum	   DAP	   plate	   (without	  antibiotic).	  Cells	  were	  mixed	  and	  swirled	  in	  the	  middle	  of	  the	  plate	  and	  then	  incubated	  at	  37	  degrees	  for	  about	  8	  hours.	  Afterwards,	  cells	  were	  washed	  with	  medium	  to	  recover	  the	   cells,	   centrifuged	   at	   3500g	   5	   min	   and	   plated	   in	   serum-­‐selective	   plates	   (without	  DAP!).	  Plates	  were	   incubated	  at	  37°C	  under	  microaerophilic	   conditions	   from	  3-­‐4	  days	  (modifyed	  from	  Webster	  D,	  2012).	  	  




	  2.2.2	  Biochemical	  methods	  	  	  
2.2.2.1	  Western	  Blot	  	  Sample	  preparation:	  	  
E.	  coli	  For	   Western	   blot	   experiments;	   300µl	   of	   overnight	   cultures	   of	   E.	   coli	   containing	   the	  desired	  plasmid	  and	  the	  selective	  antibiotic	  were	   inoculated	   in	  20	  ml	  of	  medium	  until	  reaching	  an	  OD420	  nm	  of	  1.0.	  The	  cells	  were	   then	   induced	  with	   IPTG	  (0.5M)	   for	  2	  h	  at	  37°C.	   Harvested	   by	   centrifugation	   for	   10	   min	   at	   5000rpm	   4°C	   with	   KPi	   pH	   7.5	   and	  washed.	  Cells	  were	  resuspended	  with	  3ml	  buffer/g	  of	  cell	  wet	  weight	  and	  sonified	  with	  3x30s	   with	   35%	   Amplitude	   at	   the	   Branson	   cell	   disruptor	   B15.	   The	   sample	   was	  centrifuged	   10	   min	   at	   10,000rpm	   to	   remove	   the	   cell	   debris;	   the	   supernatant	   was	  recovered	   and	   ultracentrifuged	   for	   60	   min	   at	   80,000rpm.	   The	   resulting	   pellet	   was	  resuspended	  in	  50µl	  of	  PBS	  and	  stored	  at	  -­‐20°C	  before	  use	  (Quick	  M	  S,	  et	  al.,1996).	  
H.	  pylori	  For	  Western	  blot	  experiments	   in	   the	  complemented	  mutants	   in	  H.	  pylori,	   strains	  were	  first	   amplified	   on	   plates	   for	   2	   days,	   afterwards	   grown	   for	   24	   h	   in	   liquid	   medium	  supplemented	   with	   10%	   HS	   and	   Kanamycin	   (8µg/ml)	   if	   necessary.	   Cells	   were	   spin	  down	  at	  3500	  rpm	  4°C	  and	  a	  new	  fresh	  culture	  was	  inoculated	  from	  the	  pre-­‐culture.	  Cells	   were	   harvested,	   resuspended	   in	   a	   mixture	   of	   PBS,	   complete	   and	   disrupted	   by	  sonification	   at	   3x30s	   with	   35%	   Amplitude	   at	   the	   Branson	   cell	   disruptor	   B15.	   The	  sample	  was	  centrifuged	  10	  min	  at	  10,000rpm	  to	  remove	  the	  cell	  debris;	  the	  supernatant	  was	  recovered	  and	  ultracentrifuged	  for	  60	  min	  at	  80,000rpm.	  The	  resulting	  pellet	  was	  resuspended	  in	  50µl	  of	  PBS	  and	  stored	  at	  -­‐20°C	  before	  use	  (modifyed	  from	  Quick	  M	  S,	  et	  
al.,1996).	  	  	  
2.2.2.2	  Protein	  quantification	  	  
	  Determination	   of	   protein	   was	   performed	   according	   to	   a	   modified	   Lowry	   method	  (Peterson,	   1977)	   for	   total	   membrane	   protein,	   according	   to	   Bradford	   (1976)	   for	  detergent-­‐	   solubilized	   protein,	   and	   by	   the	   Amido	   Black	   method	   (Schaffner	   and	  Weissmann,	  1973)	  for	  protein	  in	  proteoliposomes.	  	  	  	  
2.2.2.3	  Sodium	  dodecyl	  sulfate-­polyacrylamide	  gel	  electrophoresis	  (SDS-­PAGE)	  	  The	   protein	   separation	   was	   performed	   by	   SDS-­‐PAGE	   according	   to	   Lämmli	   (1970).	  Proteins	   were	   separate	   according	   to	   their	   electrophoretic	   mobility.	   SDS	   which	   is	   an	  anionic	  detergent	  was	   applied	   to	   the	  protein	   samples	   to	   linearize	   the	  proteins	   and	   to	  impart	  a	  negative	  charge	  to	  them.	  Besides	  the	  addition	  of	  SDS,	  2-­‐mercaptoethanol	  (beta-­‐mercaptoethanol/BME),	   a	   reducing	   agent	   was	   added,	   which	   further	   denatures	   the	  proteins	  by	  reducing	  disulfide	  linkages,	  thus	  overcoming	  some	  forms	  of	  tertiary	  protein	  folding,	  and	  breaking	  up	  quaternary	  protein	  structure	  (oligomeric	  subunits).	  	  The	   protein	  was	  mixed	  with	   SDS-­‐Buffer	   (2%	   (w/v)	   SDS,	   2%	   (v/v)	   Glycerin,	   0,005	  %	  (w/v)	  Bromphenolblue	  and	  25	  mM	  Tris/HCl,	  pH	  6,76)	  and	  5%	  (v/v)	  β-­‐Mercaptoethanol	  and	   then	   loaded	   on	   the	   gel.	   The	   spacer	   and	   stacking	   gel	  were	   prepared	   according	   to	  Sambrook	  et	  al.	  (1989).	  The	  acrylamide	  concentration	   in	   the	  gel	  was	  12%	  (Table	  17).	  	  




For	  E.	  coli	  cells	  0,35mg/ml	  were	  loaded	  and	  for	  H.	  pylori	  samples	  50	  µg	  of	  protein	  was	  applied	  to	  the	  gels.	  	  	  
Table	  17.	  SDS-­Gel	  preparation	  used	  in	  this	  study	  
Reagent	   Spacergel	   Stackingel	  
Acrylamid	  (%)	   4,9	   12,5	  
5	  x	  SpacerBuffer	  
(0,4%	  (w/v)	  SDS,	  1,5	  M	  Tris/HCl,	  pH8,8)	  
-­‐	   6	  ml	  
5	  x	  Stackingbuffer	  
(0,4%	  (w/v)	  SDS,	  0,5	  M	  Tris/HCl,	  pH	  6,6)	  
2,5	  ml	   -­‐	  
APS	  (10%)	   45	  µl	   160	  µl	  
TEMED	   15	  µl	   16	  µl	  
H2Obidest	   5,86	  ml	   8	  ml	  	  	  The	  PageRuler™	  Prestained	  Protein	  Ladder	  Standard	  (Fermentas)	  was	  used	  as	  protein	  standard.	  And	  the	  electrophoresis	  was	  performed	  at	  200	  V	  for	  1	  h	  in	  SDS	  1x	  buffer	  	  
2.2.2.4	  Detection	  of	  proteins	  in	  polyacrylamide-­gels	  After	   the	   electrophoresis,	   proteins	   in	   polyacrilamide	   gels	   can	   be	   stained	   to	   be	  visualized.	   Detection	   can	   be	   performed	   using	   the	   Comassie	   solution	   (Marshall	   and	  Williams,	  1992).	  Therefore,	  SDS	  gels	  were	  incubated	  with	  the	  Coomassie	  solution	  for	  20	  min	  with	  gentle	  agitation.	  Afterwards,	  gels	  were	  destained	   in	  destaining	  solution.	  The	  solution	  was	  several	  times	  replenished	  until	  background	  of	  the	  gel	  was	  fully	  destained.	  A	  the	  end,	  the	  destained	  gel	  was	  dryed	  and	  stored	  	  
2.2.2.5	  Immunological	  analysis	  for	  proteins	  with	  a	  His-­tag	  For	   Western	   blot	   experiments,	   the	   proteins	   were	   transferred	   to	   nitrocellulose	  membranes	  (Schleicher	  &	  Schuell)	  by	  the	  method	  of	  Towbin	  et	  al,	  1979.	  	  The	  blots	  were	  first	  incubated	  with	  blocking	  Buffer	  for	  1	  h	  to	  avoid	  unspecific	  binding.	  Washed	   10	   min	   with	   TBS	   buffer	   and	   then	   incubated	   either	   with	   a	   Penta	   His	   HRP-­‐conjugate	  mouse	  antibody	  raised	  against	  a	  synthetic	  His-­‐tag	  at	   the	  HpputP	  C-­‐terminus	  or	  with	  an	  antibody	  raised	  against	  GFP	  fused	  to	  the	  C-­‐	  terminal	  part	  of	  HpputP	  in	  the	  H.	  
pylori	  complementation	  plasmids.	  Both	  antibodies	  were	  used	  in	  a	  dilution	  of	  1:20,000.	  Finally	   the	   blot	   was	   washed	   twice	   with	   TBS-­‐TT	   buffer	   and	   bound	   antibodies	   were	  visualized	  with	  an	  Uptima-­‐uptilight	  HRP	  blot	  substrate	  	  	  
2.2.2.6	  Protein	  Purification	  	  For	   the	   purification	   of	  H.	   pylori	   PutP	   preparation	   of	   inverted	  membrane	   vesicles	  was	  performed	   first.	   For	   this,	   E.	   coli	   WG170	   harboring	   plasmid	   pRHpputP6H	   was	   grown	  aerobically	   in	   LB	  medium	   containing	   100	  mg/mL	   ampicillin	   at	   37	   °C,	   and	   expression	  




was	  initiated	  by	  addition	  of	  0.3	  mM	  isopropyl	  thio-­‐ß-­‐Dgalactoside	  (IPTG)	  at	  the	  middle	  of	  the	  exponential	  growth	  phase.	  After	  further	  growth	  for	  3	  h,	  cells	  were	  harvested	  by	  centrifugation,	   washed	   with	   100	   mM	   KPi,	   pH	   7.5/2	   mM	   ß-­‐mercaptoethanol,	   and	  resuspended	   in	   the	   same	   buffer	   to	   give	   0.4	   g	   of	   cells	   (wet	   weight)/mL.	   Inverted	  membrane	   vesicles	  were	   prepared	   by	   passage	   of	   the	   cell	   suspension	   through	   a	   high-­‐pressure	  cell	  disruptor	  followed	  by	  low-­‐speed	  centrifugation	  at	  12000g	  for	  30	  min	  at	  4	  °C	  to	  remove	  unbroken	  cells.	  Membranes	  were	  collected	  by	  centrifugation	  at	  230000	  xg	  for	  90	  min	  at	  4	  °C,	  washed	  with	  25	  mM	  Tris	  pH	  7.5,	  300	  mM	  NaCl,	  10%	  Glycerol,	  2	  mM	  ß-­‐Mercaptoethanol,	  resuspended	  in	  the	  same	  buffer,	  and	  stored	  at	  -­‐80	  °C	  (Jung	  H	  et	  al.,	  1998b).	  	  For	  solubilization	  of	  HpPutP,	  inverted	  membrane	  vesicles	  were	  diluted	  into	  50	  mM	  KPi,	  pH	  8.0,	   to	  yield	  a	  protein	  concentration	  of	  10	  mg/mL.	  The	  membrane	  suspension	  was	  supplemented	   with	   2	   mM	   ß	   -­‐mercaptoethanol	   and	   10%	   glycerol.	   n-­‐Dodecyl-­‐ß-­‐D-­‐pyranosid	  (DDM)	  was	  added	  stepwise	  to	  yield	  a	  final	  concentration	  of	  1.5%	  (w/v)	  while	  stirring	  on	  ice.	  After	  additional	  stirring	  for	  30	  min,	  the	  sample	  was	  centrifuged	  at	  230,	  000g	  for	  20	  min	  The	  protein	  purification	  was	  performed	  in	  an	  Äkta	  Purifier	  (GE	  Healthcare)	  instrument,	  in	  which	  a	  cartridge	  pre-­‐filled	  with	  Ni-­‐NTA	  Superflow	  was	  used	  (Quiagen).	  Finally	   the	  column	  was	  equilibrated	  with	  washing	  buffer	  (25	  mM	  Tris	  pH7.5,	  300	  mM	  NaCl,	  2	  mM	  ß-­‐Mercaptoethanol,	   0,04%	   DDM,	   0,01	   M	   Imidazol	   pH8.0)	   and	   loaded	   with	   the	  solubilized	  protein.	  The	  protein	  was	  finally	  eluted	  by	  using	  an	  elution	  gradient	  with	  the	  washing	  buffer	  up	  to	  200	  mM	  Imidazol.	  	  	  	  
2.2.2.7	  Functional	  reconstitution	  of	  HpPutP	  First,	   lipids	  were	  prepared;	   therefore	   an	   appropriate	   amount	  of	   lipids	  was	   transfered	  into	   a	   large	   beaker	   or	   flask	   (e.g.,	   15	   ml	   chloroform	   containing	   300	   mg	   lipids).	  Chloroform	  was	  removed	  under	  a	  stream	  of	  argon	   to	  obtain	  a	   thin	   layer	  of	  dry	   lipids.	  The	  lipids	  were	  resuspended	  in	  argon	  saturated	  buffer	  PL	  [100	  mM	  KPi	  pH	  7.5/	  2	  mM	  β-­‐Mercaptoethanol/	   1.5	  %	   octylglucoside	   (w/v)	   (This	   OG	   concentration	   corresponds	   to	  the	  onset	  of	  lipid	  solubilisation)	  (e.g.,	  add	  15	  ml	  buffer	  PL	  to	  300	  mg	  of	  lipids	  to	  obtain	  20	  mg	  lipids/ml).	  Aliquots	  of	  the	  lipids	  were	  frozen	  and	  stored	  in	  liquid	  nitrogen	  The	   permease	   used	   was	   purified	   by	   Ni-­‐NTA	   chromatography	   in	   0.04	   %	  dodecylmaltoside	  (w/v).	  	  	  The	   pretreatment	   of	   biobeads	   was	   performed	   as	   previously	   described	   (According	   to	  Holloway	   P.W.	   1973).	   Work	   was	   done	   at	   room	   temperature.	   	   200	   ml	   methanol	   was	  added	  to	  30	  g	  Bio-­‐Beads	  SM-­‐2	  (BioRad)	  and	  stirred	  for	  15	  min.	  Beads	  were	  collected	  on	  sintered	  glass	  funnel	  and	  washed	  with	  further	  500	  ml	  Methanol.	  Immediately	  after	  the	  beads	  were	  washed	  with	  1000	  ml	  water	  (The	  beads	  are	  not	  allowed	  to	  dry).	  The	  moist	  beads	  were	  washed	  slowly	  with	  2000	  ml	  water	  using	  a	  chromatography	  column.	  Beads	  were	   stored	   under	  water	   until	   required	   and	   finally	  washed	  with	   100	  mM	  KPi	   pH	  7.5	  before	  use.	  Finally,	  for	  the	  protein	  reconstitution,	  lipids	  were	  thawed	  and	  extruded	  through	  400nm	  filter,	  lipids	  were	  adjusted	  to	  a	  final	  concentration	  of	  	  5mg/ml	  with	  100mM	  Kpi	  pH	  7.5	  (room	   temperature)	   and	   destabilized	  with	   0.12%	   Triton	   X-­‐100.	   Afterwards	   biobeads	  were	  added.	  Lipids	  were	  mixed	  with	  purified	  permease	  at	   the	  desired	   lipid	   to	  protein	  ratio	  [e.g.,	  150	  to	  1	  (w/w)]	  and	  incubated	  at	  room	  temperature	  under	  gentle	  agitation	  for	  15	  min.	  Biobeads	  were	  added	  [beads	  to	  detergent	  ratios:	  5	  mg	  beads	  (wet	  weight)	  to	  




1	  mg	  Triton	  X-­‐100;	  10	  mg	  beads	  (wet	  weight)	  to	  1	  mg	  DM]	  	  	  (e.g.,	  add	  260	  mg	  biobeads	  to	  a	  solution	  containing	  50	  mg	  Triton	  X-­‐100	  and	  1	  mg	  DM)	  This	   mixture	   was	   incubated	   at	   room	   temperature	   under	   gentle	   agitation	   for	   1	   h.	  Afterwards	  the	  same	  amount	  of	  biobeads	  was	  added	  again	  and	  incubation	  continued	  at	  room	  temperature	  under	  gentle	  agitation	  for	  further	  1	  h.	  	  More	   biobeads	   (double	   amount	   as	   above)	   were	   added	   for	   the	   third	   time	   and	   then	  incubated	  at	  4°C	  under	  gentle	  agitation	  overnight.	  Biobeads	  were	  removed	  by	  filtration	  on	  glass	   silk	  or	  by	  pipetting	   carefully	  using	  a	  narrow	  pipette	   tip.	  The	  proteoliposome	  suspension	   was	   dialyzed	   two	   times	   against	   2	   l	   of	   100	   mM	   KPi	   pH	   7.5/	   2mM	   β-­‐Mercaptoethanol	   at	   4°C.	   Proteoliposomes	   were	   concentrated	   by	   centrifugation	   and	  stored	  in	  liquid	  nitrogen	  (Jung	  H	  et	  al.,	  1998b).	  	  	  	  
2.2.2.8	  Determination	  of	  Na+	  	  Na+	  concentrations	  in	  buffers	  used	  for	  transport	  assays	  were	  determined	  with	  a	  Varian	  AA240	  atomic	  absorption	  spectrometer.	  	  	  	  
2.2.2.9	  Transport	  experiments	  	  
2.2.2.9.1	  14C	  L-­proline-­uptake	  of	  HpPutP	  in	  proteoliposomes	  An	   aliquot	   of	   the	   proteoliposomes	  was	   resuspended	   in	   Buffer	   1	   (100	  mM	  KPi,	   5	  mM	  MgCl2,	   2	   mM	   ß-­‐Mercaptoethanol)	   and	   extruded	   through	   a	   400nm	   polycarbonat	  membrane	  filter.	  	  The	  extruded	  proteoliposomes	  were	  sedimented	  at	  180,	  000	  g	  for	  30	  min	  at	  20°C	  and	  resuspended	   in	   the	   minimum	   amount	   of	   buffer	   1.	   The	   14C	   L-­‐proline	   uptake	   in	  proteoliposomes	  was	  performed	  under	  different	  conditions	  Buffer	  1	  (100	  mM	  KPi,	  5	  mM	  MgCl2,	   2	  mM	  ß-­‐	  Mercaptoethanol,	   negative	   control);	   Buffer	   2	   (∆µNa+):	   100	  mM	  Tris/	  Mes	  pH	  7.5,	  5	  mM	  MgCl2,	  2	  mM	  ß-­‐	  Mercaptoethanol,	  50	  mM	  NaCl;	  Buffer	  3	  (∆µLi+):	  100	  mM	  Tris/	  Mes	  pH	  7.5	  (Na+-­‐	  free),	  5	  mM	  MgCl2,	  2	  mM	  ß-­‐	  Mercaptoethanol,	  50	  mM	  LiCl;	  Buffer	   4	   (∆µH+):	   100	   mM	   Tris/	   Mes	   pH	   6.0	   (Na+-­‐	   free),	   5	   mM	   MgCl2,	   2	   mM	   ß-­‐	  Mercaptoethanol;	  Buffer	  5	  (∆µNa+,	  pH):	  100	  mM	  Tris/	  Mes	  pH	  6.0,	  5	  mM	  MgCl2,	  2	  mM	  ß-­‐	  Mercaptoethanol,	  50	  mM	  NaCl,	  2	  mM).	  For	  the	  measurements,	  400µl	  of	  the	  buffers	  together	  with	  10	  µM	  14C-­‐	  L-­‐	  proline	  (26Ci/	  mol)	  were	  incubated	  at	  25°C	  for	  5	  min.	  Immediately	  before	  starting	  the	  reaction,	  1µl	  of	  proteoliposomes	  and	  Valinomycin	  with	  an	  end-­‐concentration	  of	  0.2µM	  were	  added.	  The	  reaction	  was	  stopped	  after	  different	  time	  intervals	  by	  adding	  twice	  3ml	  of	  cold	  calcium	  lithium	   stop	   buffer.	   Proteoliposomes	   were	   filtered	   in	   cellulose-­‐ester-­‐filters	   (0.22	   µM,	  Millipore)	   which	   were	   transferred	   into	   scintillation	   vials	   with	   4.5	   ml	   of	   scintillation	  liquid	   (EcoLite;	  MP	  Biomedicals).	   Radioactivity	   of	   bacteria	   retained	  on	   the	   filters	  was	  quantified	  using	  a	  ß-­‐Counter.	  	  	  
2.2.2.9.2	  14C	  L-­proline-­uptake	  of	  HpPutP	  in	  E.	  coli	  Active	   transport	   was	   measured	   in	   E.	   coli	   WG170	   (ΔputPA)	   harboring	   derivatives	   of	  plasmids	   pTHpputP6H	   or	   encoding	   HpputP	   (HPP12_0049)	   with	   given	   nucleotide	  replacements.	   The	   cells	   were	   grown	   aerobically	   in	   Luria-­‐Bertani	   (LB)	   medium	  containing	  100	  μg/mL	  ampicillin	  at	  37	  °C.	  Overnight	  cultures	  were	  diluted	  25-­‐fold	  and	  were	   allowed	   to	   grow	  up	   to	   an	   optical	   density	   at	   420	  nm	   (OD420)	   of	   1.0,	   followed	  by	  




induction	   with	   0.5	   mM	   IPTG	   for	   2	   hours.	   Cells	   were	   harvested	   by	   centrifugation	   at	  13,200	  xg	  for	  10	  min	  and	  washed	  up	  to	  2	  times	  with	  100	  mM	  Tris/Mes,	  pH	  6.0	  at	  4	  °C.	  For	  transport	  assays,	  cells	  were	  resuspended	  in	  the	  same	  buffer	  and	  adjusted	  to	  a	  total	  protein	   concentration	   of	   0.35	  mg/mL.	   Transport	   of	   10	   μM	   14C-­‐	   L-­‐proline	   (26	   Ci/mol)	  was	   assayed	  under	   standard	   test	   conditions	   in	   the	   presence	   of	   20	  mM	  D-­‐lactate	   (Na+	  salt)	   and	   50	  mM	   NaCl.	   Transport	   assays	   were	   determined	   at	   various	   time	   points	   (0,	  0.17,	  0.5,	  1,	  2,	  5,	  10,	  30	  min)	  using	  the	  rapid	  filtration	  method	  as	  described	  by	  Jung	  et	  al.	  1998.	  Initial	  rates	  of	  transport	  were	  calculated	  from	  the	  initial	  linear	  portion	  of	  the	  time	  course.	   Standard	   deviations	   were	   determined	   from	   at	   least	   three	   independent	  experiments.	  	  	  	  
2.2.2.9.3	  Proline	  kinetic	  of	  HpPutP	  in	  E.	  coli	  
E.	  coli	  WG170	  Cells,	  with	  the	   	  pTHpputP6H	  plasmid	  were	  cultured	  and	  prepared	  as	  for	  the	   14C	   L-­‐proline	   uptake	   of	   HpPutP	   in	   E.coli.	   200µl	   of	   the	   cell	   suspension	   was	  preincubated	  with	  20	  mM	  D-­‐lactat	  at	  25°C	  for	  5	  min.	  The	  reaction	  was	  started	  with	  the	  addition	   of	   50	   mM	   NaCl	   and	   different	   concentrations	   of	   14C-­‐L-­‐proline.	   The	   transport	  measurements	  were	  carried	  out	  with	  9	  different	  14C-­‐L-­‐proline	  concentrations	  from	  0.12	  µM	  to	  100	  µM.	  For	  each	  14C-­‐L-­‐proline	  concentrations	  two	  time	  points	  mere	  measured,	  0	  and	  10	  sec.	  The	  reaction	  was	  stopped	  as	  previously	  described.	  Finally,	  for	  each	  reaction	  of	   different	   concentrations	   of	   14C-­‐L-­‐proline	   the	   velocity	   of	   the	   reaction	   v	  (nmol/mg*min)	  was	  calculated	  based	  on	  the	  difference	  of	  the	  two	  measurements.	  	  	  
2.2.2.9.4	  14C	  L-­proline	  uptake	  by	  HpPutP	  in	  H.	  pylori	  The	  procedure	  was	  adapted	  from	  that	  used	  by	  Leduc	  D,	  et	  al.	  in	  2010.	  H.	  pylori	  parental	  strain	  and	  the	  isogenic	  knockout	  single	  or	  double	  mutants	  were	  amplified	  on	  plates	  for	  2	   days,	   grown	   in	   25ml	   liquid	   medium	   supplemented	   with	   10%	   HS	   and	   the	  corresponding	   antibiotic	   if	   necessary	   for	   24	   h.	   Afterwards,	   cells	   were	   spin	   down	   	   at	  3500	  rpm	  4°C	  and	  a	  new	  fresh	  50ml	  	  culture	  was	  inoculated	  from	  the	  pre-­‐culture.	  After	  12h	  this	  late	  log	  cells	  were	  collected	  by	  centrifugation	  and	  washed	  with	  100	  mM	  Tris-­‐morpholineethanesulfonic	   acid	   (MES)	   buffer,	   pH	   7.0,	   with	   150mM	   KCl.	   Cells	   were	  adjusted	  to	  an	  OD600	  of	  0.8	  and	  from	  the	  prepared	  suspension,	  aliquots	  of	  200	  µl	  were	  added	   to	   the	   reaction	   tubes	   and	   kept	   at	   37°C	   until	   use.	   Directly	   before	   starting	   the	  reaction	  50	  mM	  NaCl	  and	  2	  µl	  of	  14C	  L-­‐proline	  1mM	  were	  added	  and	  mixed	  quickly.	  The	  samples	   were	   incubated	   depending	   of	   the	   required	   time	   interval	   and	   immediately	  filtrated	   on	   Durapore	   0.45-­‐µm	   membrane	   filters	   (Millipore)	   that	   were	   abundantly	  washed	  with	  3	  ml	  of	  cold	  Stop-­‐Buffer.	  Finally,	  filters	  were	  transferred	  into	  scintillation	  vials	   with	   4.5	   ml	   of	   scintillation	   liquid	   (EcoLite;	   MP	   Biomedicals).	   Radioactivity	   of	  bacteria	  retained	  on	  the	  filters	  was	  quantified	  by	  liquid	  scintillation	  counting.	  	  
	  
2.2.2.9.5	  Proline	  kinetics	  of	  HpPutP	  in	  H.	  pylori	  Cell	  cultures	  were	  grown,	  harvested	  and	  prepared	  as	  those	  for	  the	  14C	  L	  proline-­‐uptake	  of	   HpPutP	   in	   H.	   pylori	   as	   mentioned	   above.	   200µl	   of	   the	   cell	   suspension	   was	  preincubated	   at	   37°C	  until	   use.	   The	   reaction	  was	   started	  with	   the	   addition	   of	   50	  mM	  NaCl	  and	  different	   concentrations	  of	   14C-­‐L-­‐proline.	  The	   transport	  measurements	  were	  carried	  out	  with	  9	  different	  14C-­‐L-­‐proline	  concentrations	  from	  0.12	  µM	  to	  100	  µM.	  For	  




each	   14C-­‐L-­‐proline	   concentrations	   two	   time	  points	  were	  measured,	   0	   and	   10	   sec.	   The	  samples	   were	   incubated	   for	   1	   min	   and	   immediately	   filtrated	   on	   Durapore	   0.45-­‐µm	  membrane	   filters	   (Millipore)	   that	   were	   abundantly	   washed	   with	   3	   ml	   of	   cold	   Stop-­‐Buffer.	  The	  reaction	  was	  stopped	  as	  previously	  described.	  Finally,	   for	  each	  reaction	  of	  different	  concentrations	  of	   14C-­‐L-­‐proline	  the	  velocity	  of	   the	  reaction	  v	  (nmol/mg*min)	  was	  calculated	  based	  on	  the	  difference	  of	  the	  two	  measurements.	  	  	  
	  
2.2.2.9.6	  Sodium	  kinetic	  of	  HpPutP	  in	  H	  pylori	  Cell	  cultures	  were	  grown,	  as	  those	  for	  the	  14C	  L-­‐proline	  uptake	  of	  HpPutP	  in	  H.	  pylori	  as	  mentioned	  above.	  Cells	  were	  washed	  for	  5	  times	  with	  Na+-­‐free	  100	  mM	  Tris-­‐MES	  buffer,	  pH	   7.0,	  with	   150mM	  KCl	   and	   the	   cell	   suspension	  was	   adjusted	   to	   an	  OD600nm	  of	   8.0.	  Aliquots	  of	  200µl	  of	  the	  cell	  suspension	  were	  kept	  at	  37°C	  until	  use.	  Before	  starting	  the	  transport	  reaction	  10	  µM	  14C-­‐L-­‐proline	  and	  different	  concentrations	  of	  NaCl	  (5	  µM-­‐	  250	  mM)	  were	  added.	  The	  reaction	  time	  point	  was	  1	  min	  and	  for	  the	  0	  time	  point	  just	  one	  Na+-­‐concentration	  was	  measured.	   The	   velocity	   of	   the	   reaction	   v	   (nmol/mg*min)	  was	  calculated	  based	  on	  the	  difference	  of	  the	  measurements	  at	  1	  min	  minus	  the	  0	  time	  point	  measurement.	  For	  the	  determination	  of	  the	  K0.5	  [Na+],	  the	  measurement	  of	  the	  Na+	  concentration	  in	  the	  cell	  suspension	  was	  considered	  in	  the	  calculations;	  therefore,	  it	  was	  determined	  with	  an	  atomic	  absorption	  spectrophotometer	  All	  kinetic	  analysis	  in	  this	  work,	  either	  for	  sodium	  or	  14C	  L-­‐proline	  uptake	  were	  based	  on	  the	  Michaelis-­‐Menten	  Kinetics	  Equation	  of	  Michaelis-­‐Menten:	  
v	  =	  Vmax	  x	  [S]	  /	  Km	  +	  [S]	  v	  =	  velocity;	  [S]	  =	  Substrate	  concentration;	  Km	  =	  Michaelis-­‐constant;	  Vmax	  =	  maximum	  rate	  Lineweaver-­‐Burke:	  
1/v	  =	  1/[S]	  x	  Km/Vmax	  +	  1/Vmax	  Eadie-­‐Hofstee:	  
	  	  v	  =	  Vmax	  –	  (Km	  x	  V)	  /	  [S]	  
	  
	  
2.2.2.10	  ATP	  measurements	  To	  determine	  the	  ATP	  levels	  in	  H.	  pylori	  cells,	  the	  BacTiter-­‐Glo™	  Microbial	  Cell	  Viability	  Assay	   (Promega)	   was	   used.	   Briefly,	   samples	   were	   collected	   from	   liquid	   cultures	   in	  logarithmic	   phase,	   adjusted	   to	   an	   OD600	   of	   1	   in	   an	   opaque-­‐welled	   multiwell	   plate	   in	  




culture	  medium	  (e.g.,	  100μl	  for	  each	  well	  of	  a	  96-­‐well	  plate).	   	  Control	  wells	  containing	  medium	  without	  cells	  were	  prepared	  to	  obtain	  a	  value	  for	  background	  luminescence.	  The	   BacTiter-­‐Glo™	   Reagent	   was	   added	   in	   an	   equal	   volume	   of	   cell	   culture	   medium	  present	  in	  each	  well	  (e.g.,	  add	  100μl	  of	  reagent	  to	  100μl	  of	  medium	  containing	  cells	  for	  the	  96-­‐well	  plate	  format).	  The	  content	  was	  mixed	  briefly	  on	  a	  shaker	  and	  incubated	  for	  five	  minutes	  and	  luminescence	  was	  recorded.	  For	  the	  calculations,	  a	  standard	  curve	  was	  prepared	  with	  10-­‐fold	  serial	  dilutions	  of	  ATP	  in	  culture	  medium	  (1μM	  to	  10pMof	  ATP).	  
	  
	  
2.2.3	  Molecular	  Methods	  	  	  
2.2.3.1	  Isolation	  of	  Plasmid-­DNA	  of	  E.	  coli	  Plasmid	   DNA	   of	   E.	   coli	   was	   extracted	   using	   the	   HiYield	   Plasmid	   Mini	   DNA-­‐kit	   (SLG),	  according	  to	  the	  manufacturer’s	  instructions	  	  	  
2.2.3.2	  Extraction	  of	  genomic	  DNA	  from	  H.	  pylori	  Genomic	  DNA	   from	  2-­‐day-­‐old	  H.	  pylori	  plate	   cultures	  or	   late-­‐log	  phase	   liquid	   cultures	  was	   extracted	   by	   following	   the	   ReliaPrep	   gDNA	   Tissues	  Miniprep	   system	   (Promega).	  The	  genomic	  DNA	  was	  then	  quantified	  using	  the	  Nanodrop	  ND-­‐100	  (Nanodrop).	  	  	  
2.2.3.3	  Isolation	  of	  RNA	  H.	  pylori	  RNA	   was	   extracted	   from	   H.	   pylori	   strain	   P12	   or	   from	   the	   ΔHpputP,	   ΔHpputA	   and	  
ΔHpputAP	   mutants	   from	   cells	   grown	   in	   liquid	   culture	   at	   the	   late-­‐log	   phase	   using	   the	  Quick-­‐RNA™	  MiniPrep	   (Zymo	  Research)	   according	   to	   the	  manufacturer’s	   instructions.	  	  RNA	   prepared	   was	   analyzed	   by	   gel	   electrophoresis	   for	   no	   sign	   of	   degradation	   and	  quantified	  by	  NanoDrop	  ND-­‐100	  (Peqlab)	  	  	  
2.2.3.4	  Polymerase-­chain	  reaction	  PCRs	   were	   performed	   in	   Mastercycler	   personal	   thermal	   cycler	   (Eppendorff).	   In	   each	  reaction	  mixture,	   target	   DNA,	   reaction	   buffer,	   5	   µmol	   of	   each	   primer,	  Taq	   or	  Phusion	  polymerase	  according	   to	   the	  sample	  and	  standard	  concentrations	  of	  deoxynucleotides	  were	  included.	  As	  target	  DNA,	  purified	  genomic	  DNA	  or	  plasmid	  DNA	  preparations	  were	  used.	  When	  using	  Taq	  polymerase,	  the	  PCR	  mixtures	  were	  denatured	  at	  94°C	  for	  1	  min,	  annealed	  at	   temperatures	  between	  50	  and	  60°C	   (depending	  on	   the	  calculated	  melting	  temperatures	  of	   the	  primers)	   for	  0.5	   to	  1	  min,	  and	  extended	  at	  72°C	   for	  1	   to	  3	  min.	  A	  total	  of	  35	  cycles	  was	  performed.	  	  When	  using	  Phusion	  polymerase,	  the	  PCR	  mixtures	  were	  denatured	  at	  98°C	  for	  10	  sec,	  annealed	   at	   temperatures	   between	   50-­‐	   60°C	   (depending	   on	   the	   calculated	   melting	  temperatures	  of	  the	  primers)	  for	  30-­‐45sec,	  and	  extended	  at	  72°C	  for	  1	  to	  3	  min.	  A	  total	  of	  35	  cycles	  was	  performed.	  	  
2.2.3.5	  DNA-­Gel	  electrophoresis	  For	  the	  analysis	  of	  the	  separation	  of	  DNA	  fragments,	  agarose	  gels	  from	  1-­‐2%	  were	  used.	  Agarose	  was	  dissolved	  in	  1x	  TAE	  Buffer	  and	  run	  at	  100V	  for	  40	  min.	  To	  make	  DNA	  or	  RNA	  bands	  visible	  for	  agarose	  gel	  electrophoresis	  ethidium	  bromide	  (EtBr)	  was	  used	  (1	  mg/l).	  It	  fluoresces	  under	  UV	  light	  when	  intercalated	  into	  the	  major	  groove	  of	  DNA	  (or	  




RNA).	  By	  running	  DNA	  through	  an	  EtBr-­‐treated	  gel	  and	  visualizing	  it	  with	  UV	  light,	  any	  band	  containing	  more	  than	  ~20	  ng	  DNA	  becomes	  distinctly	  visible	  
	  
	  
2.2.3.6	  DNA	  restriction	  by	  restriction	  enzymes	  	  Restriction	   of	   the	   desired	  PCR	   fragments,	  were	   done	   according	   to	   the	  manufacturer’s	  instructions.	  Restriction	  was	  performed	  for	  2	  h	  at	  37°C	  	  	  
2.2.3.7	  Ligation	  	  Ligation	  was	  performed	  at	  16°C	  for	  2h	  or	  overnight.	  For	  cohesive	  (sticky)	  ends,	  1	  µl	  of	  T4	  DNA	  Ligase	  in	  a	  20µl	  reaction	  was	  used.	  To	  avoid	  self-­‐ligation	  of	  the	  restricted	  vector	  and	   decrease	   the	   vector	   background	   in	   the	   cloning,	   1µl	   Alkaline	   Phosphatase,	   Calf	  Intestinal	   (CIP)	   (NEB)	   was	   added	   to	   remove	   the	   5´	  phosphate	   groups	   from	   DNA,	  deoxyribonucleoside	  triphosphates.	  	  
	  	  
2.2.3.8	  Site	  directed	  mutagenesis	  Desired	  nucleotide	   substitutions	   in	   the	  HpputP	  were	  generated	  by	   two-­‐step	  PCR	  with	  
Phusion-­‐DNA	   polymerase	   using	   plasmid	   pTHpputP6H	   as	   a	   template	   and	   synthetic	  mutagenic	  oligonucleotides.	  Altered	  sequences	  were	  cloned	  into	  plasmid	  pTHpputP6H.	  Resulting	  plasmid	  DNA	  was	  verified	  by	  sequencing	  using	  an	  ABI	  3730	  device.	  	  	  
2.2.3.9	  Construction	  of	  H.	  pylori	  mutants	  The	  construction	  of	   the	  H	  pylori	  mutants	  was	  based	  on	   the	  contraselection	  procedure	  established	   by	   Dailidiene	   et	   al.	   in	   2006.	   Briefly,	   chromosomal	   inactivation	   of	   hpPutP	  (encoding	   HpPutP),	   hpPutA	   (encoding	   HpPutA),	   and	   a	   double	   mutant	   for	   both	  
hpPutP/hpPutA	  (encoding	  HpPutP	  and	  HpPutA)	  genes	  was	  performed	  in	  H.	  pylori	  strain	  P12.	  Deletions	  were	  introduced	  by	  allelic	  exchange	  using	  a	  suicide	  plasmid	  pBluescript	  SK+	   in	  which	   around	  1000	  bp	  of	   the	  5'-­‐end	   and	   the	  3'-­‐end	   regions	   flanking	   the	  open	  reading	  frame	  of	  the	  target	  gene	  and	  an	  antibiotic	  resistance	  cassette	  (rpsLerm	  cassette)	  were	   cloned.	   These	   plasmids	   were	   constructed	   and	   amplified	   in	   E.	   coli	   and	   used	   as	  suicide	  plasmids	  in	  H.	  pylori.	  H.	  pylori	  mutants	  were	  obtained	  by	  natural	  transformation	  with	   these	  suicide	  plasmids	  as	  previously	  described	  (Haas	  R.	  et	  al.,	  1993).	  The	  double	  mutant	  was	  constructed	  in	  one	  step,	  due	  to	  the	  contraselection	  property	  of	  the	  rpsLerm	  cassette.	   Correct	   chromosomal	   insertion	   of	   the	   cassette	   and	   correct	   allelic	   exchange	  were	  verified	  by	  PCR	  using	  primers	  HpputPKP1,	  HpputPKP2,	  HpputPKP3	  and	  HpputPKP4	  (Table	  3).	  
	  
	  
2.2.3.10	  Construction	  of	  H.	  pylori	  complemented	  mutants	  For	   the	   construction	   of	   the	   complementation	   mutants,	   HpputP	   was	   amplified	   with	  primers	  HpputP	   pIB6compl_s	   and	  HpputP	   pIB6compl_as	   (Table	   3)	   and	   cloned	   into	   the	  
NotI	  and	  NdeI	  sites	  of	  pIB6	  to	  obtain	  plasmid	  pIB6	  alpA	  HpputP.	  This	  plasmid	  was	  used	  for	  the	  complementation	  of	  the	  ΔHpputP	  and	  ΔHpputAP	  mutants	  by	  conjugation.	  For	  the	  quantification	  and	  verification	  of	  the	  expression	  of	  HpPutP	  in	  H.	  pylori	  we	  used	  GFP	  as	  a	  reporter	   gene	   fused	   to:	   (1)	   The	   c-­‐terminus	   of	  HpputP	   to	   give	   the	   plasmid	   pIB6	   alpA	  
HpPutP	  GFP	  (primers	  gfpXho_s	  and	  gfpXho_as),	  or	  (2)	  to	  the	  empty	  vector	  to	  give	  place	  




to	   the	   plasmid	  pIB6alpAGFP	   (primers	  gfpNde_s	   and	  gfpNot_as).	   This	   last	   plasmid	  was	  used	  as	  a	  control	  of	  expression	  of	  pIB6	  in	  H.	  pylori	  Furthermore	   2	   different	   sizes	   (310	   or	   500bp	   upstream	   of	   HpputP)	   of	   the	   putative	  
HpputP	  promoter	  region	  were	  cloned	  into	  the	  plasmid	  pIB6	  replacing	  the	  alpA	  promoter	  (plasmids	  pIB6	  310	  GFP	  and	  pIB6	  500	  GFP).	  Also	  in	  this	  case	  HpputP	  was	  cloned	  behind	  these	   promoters	   (plasmids	   pIB6	   310	   HpputP	   and	   pIB6	   500	   HputP)	   and	   also	  GFP	   was	  fused	   to	   the	  c-­‐terminus	  of	  HpputP	   to	  give	  pIB6	  310	  HpputP	  GFP	  and	  pIB6	  500	  HpputP	  
GFP	  plasmids.	  pC	  	  
2.2.3.11	  DNAseI	  digestion	  	  DNA	  was	   removed	   from	  RNA	  preparations	   by	  DNase	   I	   digestion	  with	   1	  U	  RNase-­‐free	  DNase	  I	  recombinant	  (Thermo	  scientific)	  for	  30	  min	  at	  37°C.	  To	  stop	  the	  reaction	  1µl	  of	  50mM	  EDTA	  was	  added	  and	  the	  reaction	  was	  incubated	  for	  10	  min	  at	  65°C	  
	  
	  
2.2.3.12	  Retrotranscription	  	  A	  minimum	   of	   0.5	   µg	   of	   RNA	  was	   reverse	   transcribed	   using	   random	   primer	   and	   the	  RevertAid	  First	  Strand	  cDNA	  synthesis	  kit	  (Thermo	  scientific)	  as	  per	  the	  manufacturer´s	  recommended	  protocol.	  	  	  
2.2.3.13	  Real-­time	  PCR	  	  Real-­‐time	   PCR	   primers	   for	   seven	   flagellar-­‐associated	   genes	   and	   a	   housekeeping	   gene	  (era	  HPP12_0523)	  were	  evaluated.	  Primer	  sequences	  were	  taken	  from	  Ryan,	  K	  A	  et	  al.	  2005	  and	  modified	  according	  to	  our	  strain.	  qRT-­‐PCR	  was	  performed	  using	  a	  BioRad	  IQ5	  Multicolor	  instrument	  (BioRad).	  Each	  12.5	  µl	  reaction	  contained	  400	  nM	  of	  each	  primer	  and	   12.5	   µl	   of	   IQ	   SYBR	   Green	   Supermix	   (from	   BioRad).	   Individual	   amplification	  reactions	  were	  optimized	  for	  single-­‐band	  specificity	  and	  verified	  by	  gel	  analysis	  of	  the	  pilot	   reaction	   products.	   Fold	   change	   in	   expression	   was	   calculated	   according	   to	   the	  standard	  formula	  2(-­‐ΔΔCt),	  where	  ΔΔCt	  =	  (Ct	  target–Ct	  reference)	  calibrator	  –	  (Ct	  target	  –	  Ct	  reference)	  sample.	  	  
Era	   was	   used	   as	   reference	   gene.	   We	   refer	   to	   the	   calibrator	   as	   the	   normal	   wild-­‐type	  strain	   and	   sample	   to	   the	  knockout	   strain.	   qRT-­‐PCRs	  were	   repeated	  on	   three	  different	  sets	  of	  cultures	  collected	  on	  separate	  days.	  
 	  	  
2.2.4	  Microscopy	  Methods	  	  
2.2.4.1	  Fluorescent	  microscopy	  Samples	   were	   taken	   from	   liquid	   cultures	   in	   the	   logarithmic	   phase	   and	   bacterial	  suspensions	   were	   fixed	   to	   the	   slides	   with	   poly-­‐L-­‐lysine	   to	   allow	   adhesion.	   A	   stock	  solution	  of	  poly-­‐L-­‐lysine	  (1mg/ml,	  in	  bidestilated	  water	  filtrated)	  was	  diluted	  1:20	  with	  bidestilated	  water	  to	  get	   the	  working	   solution	   (storage	  at	   -­‐20°C).	  A	   slide	  was	   covered	  with	  200	  and	  500µl	  of	  the	  working	  solution	  and	  incubated	  for	  2h	  at	  37°C	  (slides	  were	  put	  in	  petri	  dishes	  to	  prevent	  that	  dust	  particles	  set	  down	  on	  the	  slides).	  Afterwards	  the	  excess	  solution	  was	  removed	  and	  slides	  were	  let	  overnight	  at	  37°C.	  Slides	  were	  kept	  at	  room	  temperature	  until	  used.	  Samples	  were	  put	  on	  the	  slides	  and	  let	  it	  stand	  for	  20min,	  washed	  2-­‐times	  with	  PBS	  to	  remove	  unfixed	  cells.	  Fluorescence	  pictures	  were	  obtained	  using	  a	  fluorescent	  Leica	  DM-­‐IRE2	  microscope.	  




2.2.4.2	  Scanning	  electron	  microscopy	  (SEM)	  observation	  and	  image	  analysis	  For	  scanning	  electron	  microscopy	  (SEM),	  drops	  of	  the	  sample	  were	  placed	  either	  onto	  a	  glass	  slide,	  covered	  with	  a	  cover	  slip	  and	  rapidly	  frozen	  with	  liquid	  nitrogen.	  The	  cover	  slip	  was	   removed	  with	   a	   razor	   blade	   and	   the	   glass	   slide	  was	   immediately	   fixed	  with	  2.5%	  glutaraldehyde	   in	  50	  mM	  cacodylate	  buffer	  (pH	  7.0),	  postfixed	  with	  1%	  osmium	  tetroxide	   in	   fixative	   buffer,	   dehydrated	   in	   a	   graded	   series	   of	   acetone	   solutions	   and	  critical-­‐point	   dried	   after	   transfer	   to	   liquid	   CO2.	   Specimens	   were	   mounted	   on	   stubs,	  coated	  with	  3	  nm	  platinum	  using	  a	  magnetron	  sputter	  coater,	  and	  examined	  with	  a	  Zeiss	  Auriga	  scanning	  electron	  microscope	  operated	  at	  1-­‐2	  kV.	  	  	  





3.	  RESULTS	  	   	  
3.1	  Biochemical	  characterization	  of	  HpPutP	  
	  
3.1.1	  Construction	  of	  plasmids	  for	  heterologous	  expression	  of	  HpputP	  in	  E.	  
coli	  For	   characterization	   of	   the	   putative	   proline	   transporter	   of	  H.	   pylori,	   the	   genes	  
HpputP	  and	  HpputA	  from	  strain	  P12	  were	  cloned	  and	  heterologously	  expressed	  in	  E.	  coli.	  The	  cloning	  steps	  were	  performed	  using	  NEB	  technology	  according	  to	  the	   manufacturer’s	   instructions.	   Briefly,	   the	   genes	   coding	   for	   the	   selected	  proteins	  (HpPutP	  and	  HpPutA)	  were	  amplified	  by	  PCR	  and	  flanked	  with	  NcoI	  and	  
XhoI	   specific	   recombination	   sites.	   All	   the	   genes	   were	   also	   extended	   with	   a	  sequence	  coding	  for	  a	  His-­‐tag	  at	  the	  C-­‐	  terminal	  end	  of	  the	  constructs.	  The	  PCR	  products	   were	   purified	   and	   cloned	   into	   different	   destination	   vectors	   allowing	  expression	   from	   the	   promoters	   Plac	   and	   PT7	   (pTHpputP6H)	   or	   Ptrc	  (pRHpputP10H).	   For	   the	   subsequent	   experiments,	   plasmids	   were	   transformed	  into	  the	  E.	  coli	  strain	  WG170.	  	  	  
3.1.2	  Purification	  and	  functional	  reconstitution	  of	  HpPutP	  	  
3.1.2.1	  Purification	  of	  	  HpPutP	  HpPutP	  was	   purified	   according	   to	   a	   protocol	   originally	   established	   for	   EcPutP	  (Jung	   H.	   et	   al.	   1998).	   Inverted	  membrane	   vesicles	   were	   prepared	   from	   E.	   coli	  expressing	   HpputP	   from	   plasmid	   pRHpputP6H	   and	   n-­‐Dodecyl-­‐ß-­‐D-­‐maltopyranoside	   (DDM)	   was	   used	   for	   the	   subsequent	   solubilization	   and	  purification	  of	  HpPutP	  by	  Ni2+-­‐NTA	  affinity	  chromatography	  (see	  section	  2.2.2.6	  for	   details).	   The	   purified	   protein	   was	   analyzed	   by	   SDS	   PAGE	   (Figure	   7),	  according	  to	  which	  HpPutP	  falls	  within	  the	  range	  of	  38	  kDa.	  The	  molecular	  mass	  determined	  from	  the	  amino	  acid	  sequence	  (496aa)	  is	  54.04	  kDa,	  suggesting	  that	  molecular	   weight	   on	   SDS-­‐PAGE	   underestimates,	   by	   about	   16	   kDa,	   the	   true	  molecular	   weight	   of	   the	   protein.	   The	   SDS-­‐gel	   also	   revealed	   a	   band	   of	  aproximately	   78kDa	   that	   could	   correspond	   to	   the	   dimeric	   state	   of	   HpPutP.	  Membrane	  transporter	  proteins	  exist	  in	  a	  complex	  dynamic	  equilibrium	  between	  various	  oligomeric	   states	   that	   include	  monomers,	  dimers,	  dimer	  of	  dimers	   and	  higher	   order	   oligomers.	   These	   higher	   order	   oligomerization	   states	   have	   been	  proposed	  as	   important	   factors	   that	  modulate	   the	   function	   (Veenhoff	  L	  M,	  et	  al.	  2002).	  The	  amount	  of	  purified	  protein	  from	  1	  L	  culture	  was	  0.37	  mg	  and	  purity	  was	  between	  90-­‐95%.	  	  	  






Figure	  7.	  Purification	  of	  HpPutP	  heterologously	  expressed	  in	  E.	  coli.	  E.	  coli	  cells	  WG170	  were	  transformed	  with	  the	  overexpression	  plasmid	  pTHpputP6H.	  After	  solubilization	  with	  1.5%	  (w/v)	  


















Figure	   8.	   Process	   of	   protein	  







3.1.3	  Ion	  dependency	  of	  L-­proline	  uptake	  via	  HpPutP	  in	  proteoliposomes	  Proline	   uptake	   was	   meassured	   in	   E.	   coli	   lipids.	   Ion	   and	   pH	   dependency	   were	  assessed	  with	  the	  help	  of	  the	  different	  buffers	  containing	  the	  different	  coupling	  ions.	   	   The	   cation-­‐coupled	   symport	   activity	   was	   assessed	   by	   measuring	   14C-­‐L-­‐proline	   accumulation	   in	   proteoliposomes	   loaded	   with	   100	   mM	   KPi,	   pH	   7.5.	   A	  membrane	   potential	   (ΔΨ)	   and	   desired	   ion	   gradients	  were	   imposed	   across	   the	  proteoliposome	   membrane	   by	   creating	   an	   outward-­‐directed	   K+	   diffusion	  gradient	   in	   the	  presence	  of	  valinomycin	  and	  changing	   the	   ionic	  composition	  or	  pH	   of	   the	   dilution	   buffer.	   Results	   demostrated	   that	   the	   imposition	   of	   an	  electrochemical	  Na+	  or	  Li+	  gradient	  (ΔµNa+	  or	  ΔµLi+)	  lead	  to	  accumulation	  of	  14C-­‐L-­‐proline	   in	   the	  proteoliposomes	  whereas	   the	   absence	  of	   a	   driving	   force	  did	  not	  give	   significant	   transport	   activity.	   In	   addition,	   analysis	   of	   (ΔµNa+)	   Na+-­‐driven	  transport	   at	   pH	   6.0	   did	   not	   reveal	   a	   significant	   difference	   in	   transport	   activity	  compared	  to	  meassurements	  at	  neutral	  pH	  (Figure	  9).	  	  Therefore,	   determination	   of	   Na+-­‐coupled	   (Na+	   motive	   force	   (smf)-­‐driven)	  transport	  in	  proteoliposomes	  confirmed	  that	  proline	  can	  be	  transported	  coupled	  to	  Na+,	  can	  be	  substituted	  by	  Li+,	  but	  not	  by	  H+.	  	  	  	  
Figure	  9.	  Energy	  requirements	  of	  L-­proline	  uptake	  into	  proteoliposomes.	  Purified	  HpPutP	  was	  reconstituted	   in	  E.	  coli	   lipids	  and	   ion	  and	  pH	  dependency	  were	  assessed.	  For	   the	  reaction,	  400µl	  of	  the	  buffers	  together	  with	  10	  µM	  14C-­‐	  L-­‐	  proline	  (26Ci/	  mol)	  were	  incubated	  at	  25°C	  for	  5	  min.	   immediately	  before	  starting	  the	  reaction,	  1µl	  of	  proteoliposomes	  and	  valinomycin	  with	  an	  end-­‐concentration	  of	  0.2µM	  were	  added.	  The	  reaction	  was	  stopped	  after	  different	  time	  intervals	  by	   adding	   twice	   3ml	   of	   cold	   calcium	   lithium	   stop	   buffer.	   The	   plot	   shows	   from	   left	   to	   right	  transport	  in	  the	  presence	  of:	  50	  mM	  NaCl	  and	  neutral	  pH	  (∆µNa+	  pH7.5);	  with	  50	  mM	  LiCl	  (∆µLi+	  pH7.5);	  in	  the	  absence	  of	  a	  coupling	  ion	  (∆µH+);	  with	  no	  further	  additions	  (ΔΨ,	  interior	  negative);	  





3.1.4	   Inhibition	   of	   proline	   transport	   by	   proline	   analogues	   in	  
proteoliposomes	  To	  further	  analyze	  the	  specificity	  of	  HpPutP,	  we	  tested	  several	  proline	  analogues	  with	  structures	  similar	  to	  L-­‐proline	  (Table	  18).	  	  	  	  
Table	  18.	  Structures	  of	  proline	  analogues	  and	  effect	  on	  HpPutP	  activity	  	  






Figure	   10.	   Inhibition	   studies	   of	   L-­proline	   uptake	   in	   proteoliposomes.	   Transport	   was	  measured	   as	   L-­‐proline	   uptake	   into	   proteoliposomes.	   The	   plot	   shows	   transport	   of	   10μM	   14C	   L-­‐proline	   in	   the	  presence	  of	  100μM	  of	   the	   competing	  analogue.	  Bars	   represent	   from	   left	   to	   right	  transport	   in	   the	   presence	   of:	   50	  mM	  NaCl	   and	   neutral	   pH	   (∆µNa+	   pH	   7.5)	   positive	   control;	   the	  same	   conditions	   as	   before	   adding	   the	   different	   inhibitors:	   Dehydro-­‐DL-­‐proline;	   L-­‐Azetidine-­‐2-­‐carboxylic	  acid;	  D-­‐proline;	  and	  L-­‐proline	  Methylester.	  	  	  Our	   results	   for	   the	   specificity	   of	   HpPutP	   provide	   insight	   into	   the	   structural	  requirements	  for	  substrate	  recognition.	  The	  structures	  of	  the	  analogues	  that	  are	  recognized	  or	  ignored	  by	  HpPutP	  suggest	  the	  following.	  (a)	  Only	  the	  L-­‐isomer	  is	  recognized,	   indicating	   that	   the	   proline	   permease	   is	   stereospecific;	   (b)	   a	   5-­‐member	  ring	  structure	  preferentially	  interacts	  with	  the	  substrate	  binding	  pocket	  but	  a	  smaller	  4-­‐member	  ring	  molecule	  also	  fits	  into	  the	  substrate	  binding	  pocket	  of	  proline;	  and	  (c)	  modifications	  of	  the	  carboxyl	  group	  indicate	  that	  the	  charged	  carboxyl	  group	  is	  not	  essential.	  	  	  
	  
3.1.5	  Proline	  uptake	  kinetics	  in	  HpPutP	  expressed	  in	  E.	  coli	  For	   further	  characterization	  of	  HpPutP	   in	  E.	   coli,	   the	  analysis	  of	  proline	  uptake	  was	  performed	   in	  whole	  cells.	  The	  plasmid	  pTHpputP6H	  was	   transformed	   in	  E.	  





Reaction	   rate	   v	   [nmol/mg*min]	   values	   for	   the	   kinetics	   were	   calculated	   using	  SigmaPlot.	   In	   the	  Michaelis	  Menten	  graphic	   the	  reaction	  rate	  v	   is	   in	   function	  of	  the	  substrate	  concentration,	  	  in	  this	  case	  the	  proline	  concentration.	  	  When	   assayed	   over	   a	   range	   of	   proline	   concentrations,	   this	   system	   showed	  Michaelis-­‐Menten	   kinetics	   with	   a	   Km	   of	   1.3±0.5	   µM	   and	   a	   Vmax	   of	   30.8±1.7	  nmol/mg*min	  (Figure	  11).	  	  
	  
Figure	   11.	   Kinetics	   of	   14C-­L-­proline	   uptake	   into	   E.	   coli	   WG170	   containing	   the	   plasmid	  
pTHpputP6H.	  The	  reaction	  rate	  (nmol/mg	  protein)	  is	  plotted	  according	  to	  (A)	  Michaelis-­‐	  Menten	  and	   	   (B)	  Lineweaver-­‐	  Burk.	  The	  L-­‐proline	  concentration	  was	  varied	  between	  0.12	  µM	  und	  300	  µM.	   According	   to	  Michaelis	   -­‐	  Menten	   calculations	   Vmax	   corresponds	   to	   30.8±1.7	   nmol/mg*min,	  and	  Km	  to	  1.3±0.5	  	  µM.	  	  	  	  From	  theses	  assay	  we	  conclude	  that	  heterologous	  expression	  of	  HpPutP	  was	  able	  to	   complement	   an	   E.	   coli	   putP	   deletion	   mutant,	   therefore	   HpPutP	   could	   be	  involved	  in	  the	  proline	  uptake	  in	  this	  bacterium	  	  	  





using	   an	   ABI	   3730	   device.	   Transport	   measurements	   showed	   that	   most	   of	   the	  substitution	   caused	   a	   significant	   inhibition	   of	   transport	   except	   for	   the	  mutant	  W280C	  (Figure	  12).	  	  	  
	  
Figure	  12.	  Influence	  of	  amino	  acid	  replacements	  in	  HpPutP	  on	  L-­proline	  transport	  in	  E.	  coli	  






Figure	   13.	   Initial	   rate	   and	   maximal	   accumulation	   of	   L-­proline	   uptake	   in	   E.	   coli	   WG170	  
(PutP-­A-­)	   encoding	   HpputP	   with	   given	   nucleotide	   replacements.	   Cells	   were	   cultured	   as	  described	  in	  section	  2.2.2.9.2.	  Transport	  of	  10	  μM	  L-­‐14C-­‐proline	  (26	  Ci/mol)	  was	  assayed	  under	  standard	   test	   conditions	   in	   the	   presence	   of	   20	   mM	   D-­‐lactate	   (Na+	   salt)	   and	   50	   mM	   NaCl.	  Transport	  assays	  were	  determinated	  using	  the	  rapid	  filtration	  method.	  Initial	  rates	  of	  transport	  were	   calculated	   from	   the	   initial	   linear	   portion	   of	   the	   time	   course.	   Standard	   deviations	   were	  determined	  from	  at	  least	  three	  independent	  experiments.	  	  	  PCL	  (positive	  control),	  NCL	  (negative	  control).	  Na+	   refers	   to	   the	   residues	   in	   charge	   for	  Na+	   recognition.	  Pro	   refers	   to	   the	   residues	   in	  charge	  for	  proline	  recognition.	  	  	  A	  Western	  blot	  analysis	  revealed	  that	  these	  amino	  acid	  replacements	  resulted	  in	  amounts	  of	  transporter	  molecules	  in	  the	  membrane	  similar	  as	  the	  observed	  for	  HpPutP	  in	  the	  case	  of	  the	  D58C,	  W280C,	  E311C,	  S339C	  and	  T340C	  mutants.	  This	  indicates	   that	   diferences	   in	   proline	   uptake	   cannot	   be	   attributed	   to	   different	  amounts	  of	  transporter	  molecules	  in	  the	  membrane.	  Mutant	  S60C	  did	  not	  show	  activity	  even	  though	  the	  protein	  content	  was	  higher	  compared	  to	  the	  wild	  type.	  For	   the	   Y143C	  mutant,	   the	   lack	   of	   activity	  may	   be	   reduced	   in	   part	   due	   to	   the	  lower	  amounts	  of	  protein	  (Figure	  14).	  	  
	  
Figure	   14.	   Western	   blot	   analysis	   of	   HpPutP	   with	   desired	   amino	   acid	   replacements	  





3.1.7	  Homology	  model	  of	  HpPutP	  We	  used	  protein	  modeling	  to	  predict	  the	  structure	  of	  HpPutP	  from	  its	  sequence	  to	  get	  more	  insights	   into	  the	  structure/function	  relationship	  of	  the	  transporter.	  This	  is	  a	  good	  alternative	  when	  high	  resolution	  structures	  are	  not	  available	  as	  in	  the	   case	   of	   EcPutP,	   HpPutP	   or	   any	   other	   L-­‐proline	   transporting	   integral	  membrane	  protein.	  	  Insight	   into	   the	   fold	   of	   a	   member	   of	   the	   SSS	   family	   was	   gained	   by	   the	  crystallization	   of	   the	   Na+-­‐dependent	   galactose	   symporter	   vSGLT	   of	   Vibrio	  
parahaemolyticus	  (Faham	  S,	  et	  al.	  2008).	  Based	  on	  this	  and	  the	  homology	  model	  of	  EcPutP	  (Olkhova	  E,	  et	  al.	  2011)	  the	  homology	  model	  we	  designed	  of	  HpPutP	  was	   based	   on	   the	   crystal	   structure	   of	   vSGLT.	   According	   to	   our	   results	   and	  comparison	   of	   the	   generated	   HpPutP	   model	   with	   the	   recently	   published	  homology	   model	   of	   EcPutP,	   most	   of	   the	   residues	   analyzed	   either	   for	   Na+	   or	  proline	  binding	  overlap	  between	  HpPutP	  and	  EcPutP	  (Figure	  15).	  	  
	  	  
Figure	  15.	  Tertiary	  structure	  model	  of	  HpPutP	  generated	  based	  on	  the	  crystal	  structure	  of	  
vSGLT.	  A)	  Functional	  important	  residues	  in	  HpPutP	  are	  highlited	  in	  red.	  B)	  Overlay	  of	  important	  residues	  from	  HpPutP	  in	  red	  and	  EcPutP	  in	  blue.	  The	  figure	  was	  created	  with	  the	  program	  UCSF	  Chimera	  (Pettersen	  et	  al.,	  2004).	  	  
	  
3.2	  Physiological	  relevance	  of	  HpPutP	  
	  
3.2.1	  Deletion	  of	  HpputP,	  HpputA	  and	  HpputP/HpputA	  of	  H.pylori	  strain	  P12	  





has	  contributed	  a	  lot	  to	  the	  functional	  analysis	  of	  the	  gene	  products	  (Frommer	  W	  B,	  and	  O	  Ninnemann,	  1995).	  However	  characterization	  and	  confirmation	  of	   the	  function	   of	   HpPutP	   in	   H.	   pylori	   was	   needed,	   consequently,	   first,	   culture	  conditions	   were	   standardized	   for	   the	   subsequent	   construction	   of	   the	   deletion	  mutants.	  	  The	   generation	   of	   the	  H.	   pylori	   mutants	   was	   based	   on	   the	   Dailidiene	   D,	   et	   al.,	  2006	   procedure.	   This	   consists	   of	   a	   two-­‐gene	   cassette	   (1.5	   Kb)	   containing	   the	  
Campilobacter	  jejuni	  rpsL	  gene	  (dominant	  streptomycin	  susceptibility)	  upstream	  of	  an	  erythromycin	  resistance	  gene	   (Figure	  16),	   flanked	  by	  H.	  pylori	   sequences	  that	   normally	   flank	   the	   HpputP,	   HpputA	   or	   both	   HpputP/HpputA	   genes.	   The	  suicide	  plasmid	  pBluescript	  II	  SK+	  (pBSK+)	  was	  used	  for	  cloning	  procedures	  in	  E.	  
coli	  and	  transformed	  in	  H.	  pylori	  P12.	  H.	  pylori	  mutants	  were	  obtained	  by	  natural	  transformation	  according	  to	  Haas	  R,	  et	  al.,	  1993.	  	  	  
	  
	  
Figure	  16.	  Contraselection	  strategy	  for	  the	  generation	  of	  the	  H.	  pylori	  deletion	  mutants.	  	  A	  two-­‐gene	   cassette	   (rpsLerm)	   confering	   erythromycin	   resistance	   and	   stepromycin	   susceptibility	  was	  inserted	  in	  the	  middle	  of	  the	  flanking	  regions	  of	  the	  selected	  gene	  and	  cloned	  into	  the	  suicide	  vector	  pBluescript	  SK+.	  Upon	  transformation	  in	  H.	  pylori	  the	  transforming	  DNA	  was	  transferred	  to	  the	  recipient	  chromosome	  by	  homologous	  recombination	  in	  regions	  of	  sequence	  homology.	  This	  results	  in	  the	  replacement	  of	  the	  original	  sequence	  for	  the	  rpsLerm	  cassette	  and	  a	  change	  in	  the	  bacteria	  phenotype	  from	  Ermr	  to	  Erms	  (Dailidiene	  D,	  et	  al.,	  2006).	  	  PCR	  tests	  showed	  that	  the	  Ermr	  Strs	  transformants	  tested	  contained	  the	  expected	  






Figure	  17.	  PCR	  tests	  performed	  to	  confirm	  the	  Ermr	  Strs	  transformants	  in	  H.	  pylori.	  (A)	  To	  confirm	  the	  insertion	  of	  the	  two-­‐gene	  cassette	  (rpsLerm)	  in	  the	  middle	  of	  the	  flanking	  regions	  of	  the	  selected	  gene	  (HpputP,	  HpputA	  or	   in	  between	  the	  two	  genes),	  PCR	  tests	   from	  genomic	  DNA	  were	  performed	  (using	  primers:	  rpsL_s	  &	   erm_as	  or	  erm_s	  &	  rpsL_as).	  PCR	  products	   containing	  full-­‐length	   of	   HpputP	   (primers	   HpputPKP1	   &	   HpputPKP2),	   HpputA	   (primers	   HpputPKP3	   &	  
HpputPKP4)	  and	  HpPutAP	  (primers	  HpputPKP1	  &	  HpputPKP4)	  were	  also	  confirmed.	  Furthermore	  the	  right	  insertion	  of	  the	  cassete	  was	  analyzed	  with	  PCR	  (using	  primers	  HpputPKP1	  &	  rpsL_as	  and	  
HpputPKP2	  &	  erm_s)	  for	  the	  HpputP	  gene,	  (HpputPKP3	  &	  rpsL_as	  and	  HpputPKP4	  &	  erm_s)	  for	  the	  
HpputA	  gene,	  and	  finally	  (HpputPKP1	  &	  rpsL_as	  and	  HpputPKP4	  &	  erm_s)	  for	  the	  double	  deletion	  mutant.	  In	  (B)	  PCR	  products	  containing	  half-­‐length	  of	  the	  HpputP	  gene	  are	  shown,	  confirming	  the	  right	  insertion	  of	  the	  rpsLerm	  cassette	  in	  the	  ΔHpputP	  mutant.	  The	  ΔHpputA	  and	  double	  deletion	  mutant	  were	  confirmed	  using	  the	  same	  strategy.	  
	  
	  
3.2.2	   Phenotypic	   characterization	   of	   ΔHpputP,	   ΔHpputA	   or	  
ΔHpputP/HpputA	  mutants	  
	  






Figure	   18	   Growth	   curves	   of	   the	   deletion	   mutants	   H.	   pylori	   ΔHpputP,	   ΔHpputA	   or	  
ΔHpputP/HpputA	  compared	  to	  the	  Wt	  in	  complete	  medium.	  Inocula	  was	  recovered	  from	  48h	  agar	   plates	   and	   resuspended	   in	   Brucella	   Broth	   medum	   (BB).	   Cells	   were	   adjusted	   to	   1	   x	   l08	  cells/ml	  (OD600	  of	  0.2)	  in	  24-­‐well	  plates	  with	  gentle	  shaking	  (100	  r.p.m.).	  	  OD	  measuremens	  were	  performed	  over	  5	  days	  of	  culture.	  	  
	  	  
Figure	  19.	  Growth	  curves	  of	  ΔHpputP,	  ΔHpputA,	  and	  ΔHpputA/P	  compared	  to	  H	  pylori	  P12	  





In	  addition,	  we	  tried	  to	  reproduce	  the	  defined	  medium	  described	  by	  Reynolds	  D	  J	  and	   C	   W	   Penn	   in	   1994.	   These	   media	   was	   reported	   to	   support	   the	   growth	   of	  different	  strains	  in	  the	  presence	  of	  amino	  acids	  and	  BSA.	  A	  medium	  in	  which	  all	  components	   are	   chemically	   defined	   would	   facilitate	   metabolic	   studies	   of	   H.	  
pylori.	   	   However	   our	   results	   showed	   half	   of	   the	   growth	   than	   the	   one	   obtained	  with	   the	   complex	   medium	   and	   OD	   values	   decreased	   dramatically	   after	   72h	  (Figure	  20).	  
	  
	  
Figure	  20.	  Growth	  patterns	  of	  H.	  pylori	  in	  a	  defined	  medium.	  Inocula	  were	  grown	  for	  48h	  on	  agar	  plates	  then	  resuspended	  in	  RPMI	  media.	  Cells	  were	  standardized	  to	  1	  x	  l08	  cells/ml	  (OD600	  of	  0.2).	  RPMI	  medium	  was	  suplemented	  with	  a	  mixture	  containing	  amino	  acids,	  vitamins	  and	  BSA.	  OD	  600nm	  was	  recorded	  every	  24h.	  A)	  Wild	  type	  growth	  with	  RPMI	  or	  RPMI	  suplemented	  with	  the	  mixture	   previously	   described	   (defined	  medium);	   B)	   Growh	   of	   the	  ΔHpputP,	  ΔHpputA,	   and	  
ΔHpputAP	  mutants	  compared	  to	  the	  wild	  type	  in	  defined	  medium.	  
	  
	  
3.2.2.2	   Electron	  microscopy	   observation	   of	   flagella	   of	  H.	   pylori	   wild	   type	  
and	  deletion	  mutants	  In	   2008	   Nakajima	   and	   collaborators	   showed	   that	   a	   putA	   disrupted	   mutant,	  









Figure	   21.	   Electron	   microscopy	   pictures	   of	   H.	   pylori	   wild	   type	   and	   deletion	   mutants.	  Scaning	   electron	  microscopy	   of	   (A)	   bacillary	   form	  of	  H.	   pylori	  P12	   (Wt)	   at	   day	   2	   in	   logaritmic	  phase;	  (B)	  coccoid	  form	  of	  the	  Wt	  at	  day	  4	  in	  stationary	  phase;	  (C)	  bacillary	  form	  of	  H.	  pylori	  P12	  





Scanning	  electron	  microscopy	  (SEM)	  analysis	   revealed	  a	  clear	  difference	   in	   the	  morphology	  of	  the	  mutants	  compared	  to	  the	  wild	  type	  (Figure	  21).	  The	  wild	  type	  showed	  a	  bundle	  of	  polar	   flagella	   at	   the	   logarithmic	  phase	  as	  expected	   (Figure	  21A).	   On	   the	   contrary,	   at	   the	   same	   growth	   phase	   the	   three	  mutants	   lost	   their	  flagella	   (Figure	   21C,	   21E,	   21G).	   Since	   the	   motility	   of	   H.	   pylori	   depend	   on	   the	  flagella,	   this	   result	   could	   explain	   the	   loss	   of	   infectivity	   when	   these	   genes	   are	  absent	   in	  H.	  pylori.	  Furthermore,	  we	  confirmed	  the	  coccoid	  conversion	   from	  all	  the	   strains	   at	   the	   stationary	   phase	   (day	   4)	   (Figure	   21B,	   21D,	   21F,	   21H)	   as	  described	  by	  Benaissa	  M,	  et	  al.	  in	  1996.	  	  	  The	   deletion	   mutants	   were	   further	   characterized	   by	   motility	   assay	   and	   they	  showed	   no	   motility	   compared	   to	   the	   wild	   type,	   confirming	   the	   previous	  observations	  of	  the	  electron	  microscopic	  images	  (Figure	  22).	  	  
	  
Figure	  22.	  Assesment	  of	  motility	  in	  H.	  pylori	  wild	  type	  and	  deletion	  mutants.	  H.	  pylori	  cells	  were	  cultured	   in	  plates	   for	  48	  h,	   resuspended	   in	  BB	  supplemented	  with	  10%	  horse	  serum	  and	  adjusted	   to	   bacterial	   concentrations	   of	   1x	   108	   cells	   per	  ml	   (OD600	   of	   0.2).	   Bacterial	   cells	  were	  stabbed	   with	   toothpicks	   into	   plates	   containing	   brucella	   broth	   with	   0.3%	   agar	   and	   incubated	  microaerobically	  at	  37°C	  for	  5	  days.	  (A)	  Wild-­‐type	  strain	  and	  ΔHpputP;	  	  (B)	  Wild-­‐type	  strain	  and	  
ΔHpputA;	  	  (C)	  Wild-­‐type	  strain	  and	  ΔHpputAP.	  
	  
	  
3.2.3	   Complementation	   of	   the	   mutants	   ΔHpputP,	   ΔHpputA	   and	  






Figure	  23.	  Shuttle-­Vector	  pIB6.	  The	  Shuttle-­‐	  Vector	  pIB6	  was	  constructed	  based	  on	  the	  plasmid	  
pHel3.	   It	   contains	   a	   portion	   of	   a	   cryptic	  H.	   pylori-­‐Plasmids,	   a	   kanamycin	   resistence,	   a	   oriT	   for	  conjugation,	  a	  ori(colEI)	  as	  replication	  origin	  	  in	  E.	  coli,	  the	  upstream	  region	  and	  the	  promoter	  of	  the	  alpA	  and	  alpB	  genes	  from	  H.	  pylori	  and	  a	  oligolinker	  with	  the	  restriction	  sites	  for	  the	  enzymes	  
NdeI,	  SalI,	  SpeI,	  BglII	  and	  NotI	  (Barwig	  I,	  2009).	  
	  	  	  HpPutP-­‐GFP	   fusions	  were	   generated	   in	   the	   shuttle	   vector	  pIB6	   to	  monitor	   and	  visualize	  the	  expression	  of	  this	  membrane	  protein.	  It	  is	  known	  that	  protein	  tags	  such	   as	   luciferase,	  β-­‐galactosidase	   (β-­‐gal)	   and	   green	   fluorescent	   protein	   (GFP)	  can	   be	   detected	   through	   their	   innate	   activity.	   GFP	   has	   the	   advantage	   that	   it	   is	  stable	   for	  months,	   can	  be	  visualized	  easily	  via	  standard	  confocal	  or	   fluorescent	  microscopy	  and	  can	  be	  detected	  in	  living	  cells	  (Lippincot-­‐Schwartz	  J,	  2003).	  	  We	  used	  this	  stable	  fusion	  protein	  to	  detect	  HpPutP	  in	  H.	  pylori	  by	  observing	  the	  fluorescence.	   Different	   plasmids	   were	   generated	   using	   either	   a	   constitutive	  promoter	   (alpA)	   or	   the	   putative	   native	   HpputP	   promoter	   to	   evaluate	  complementation	  (Figure	  24).	  Plasmids	  with	  the	  different	  promoters	  harboring	  






Figure	   24.	   Cloning	   strategy	   for	   evaluation	   of	   the	   function	   of	   the	   expression	   system	   and	  
expression	   of	   HpputP	   in	   the	   deletion	   mutants.	   (A)	   The	   Shuttle-­‐Vector	   pIB6	   was	   used	   to	  construct	   the	  complementation	  plasmids	   for	  H.	  pylori	  deletion	  mutants.	  GFP	  was	   fused	  directly	  behind	   of	   the	   constitutive	   alpA	   promoter	   or	   to	   the	   putative	   native	   promoter	   of	   HpputP	   to	  evaluate	   the	   expression	   in	   the	   system	   (control).	   Expression	   of	   GFP	   fused	   to	   the	   C-­‐terminus	   of	  HpputP	   was	   also	   evaluated	   when	   fused	   to	   the	   two	   different	   promoter	   regions.	   And	   finally,	  
HpputP	   was	   also	   fused	   to	   both	   promoters	   without	   the	   reporter	   gene.	   (B)	   Plasmids	   were	  individually	   transformed	   in	   E.	   coli	   WM3064	   and	   afterwards	   introduced	   to	   H.	   pylori	   deletion	  mutants	  ΔHpputP	  and	  ΔHpputAP	  by	  conjugation.	  Colonies	  were	  striped	  in	  plates	  containing	  the	  resistance	  antibiotic	  (Kanamycin)	  for	  selection.	  	  	  Representative	  samples	  of	  the	  recovered	  colonies	  after	  conjugation	  are	  shown	  in	  Figure	   25.	   Fluorescent	   microscopy	   pictures	   showed	   GFP	   expression	   in	   the	  mutants	   harboring	   the	   plasmids	   containing	   GFP	   and	   no	   GFP	   expression	   was	  detected	  in	  the	  wild	  type	  where	  no	  plasmid	  was	  introduced	  (Figures	  25A-­‐C).	  The	  expression	  of	  GFP	   and	   therefore	   of	  HpPutP	   in	   the	  deletion	  mutants	   containing	  the	  HpPutP-­‐GFP	   fusion	  was	   comparable	  when	   the	   constitutive	   (Figures	  25D-­‐F)	  or	   the	   native	   promoter	   (Figures	   25G-­‐I)	   were	   present,	   indicating	   no	   additional	  requirement	  for	  the	  function	  of	  the	  native	  promoter	  in	  our	  culture	  conditions.	  The	   subcellular	   localization	   of	   GFP	   in	   the	   deletion	   mutants	   containing	   the	  plasmid	   pIB6	   with	  GFP	   immediately	   downstream	   of	   the	   constitutive	   or	   native	  promoter	  (pIB6	  alpA	  GFP,	  pIB6	  HpputPprom	  GFP)	  was	  in	  the	  cytoplasm	  (Figure	  26A).	   For	   the	   constructs	   containing	   either	   the	   constitutive	   or	   native	   promoter	  with	   the	  HpPutP-­‐GFP	   fusion	   (pIB6	  alpA	  HpputP	  GFP,	  pIB6	  HpputPprom	  HpputP	  






Figure	  25.	  Fluorescent	  microscopy	  of	   the	  wild	   type	  and	  complemented	  mutants.	  H	  pylori	  
P12	  in	   	  (A)	  phase	  contrast;	  (B)	  GFP;	  (C)	  overlay.	  The	  deletion	  mutant,	  ΔHpputP,	  harboring	  pIB6	  
alpA	  GFP	  (positive	  control	  of	  the	  expression	  system	  in	  H.	  pylori)	  in	  (D)	  phase	  contrast;	  (E)	  GFP;	  
(F)	  overlay.	  Deletion	  mutant,	  ΔHpputP,	  complemented	  with	  pIB6	  alpA	  HpputP	  GFP	   in	  (G)	  phase	  contrast;	  (H)	  GFP;	  (I)	  overlay.	  	  
	  
Figure	   26.	   Fluorescent	   microscopy	   of	   H.	   pylori	   ΔHpputP	   deletion	   mutant	   harboring	   a	  





about	  65	  kDa,	  16	  kDa	  below	  the	  theoretical	  size.	  This	  is	  again	  due	  to	  the	  typical	  faster	  migration	  of	  membrane	  proteins	  observed	   in	  SDS-­‐Gels.	  Nevertheless,	   the	  	  size	   of	   65	   kDa	   observed	   for	   the	   fusion	   protein	   is	   in	   full	   agreement	   with	   the	  experimental	  molecular	  weight	  of	  the	  transporter	  (38	  kDa)	  alone	  plus	  the	  weight	  of	  GFP	  (27	  kDa).	  	  	  
	  
Figure	  27.	  Western	  blot	  analysis	  of	  HpPutP	  in	  H.	  pylori.	  H.	  pylori	  samples	  were	  prepared	  from	  liquid	  cultures	  in	  the	  log	  phase.	  Cells	  were	  disrupted	  by	  sonification	  and	  membranes	  were	  loaded	  on	   a	   SDS-­‐PAGE	   gel.	   Polyacrylamid	   gel	  was	   transferred	   to	   a	   nitrocellulose	  membrane	   and	   then	  incubated	  with	  anti-­‐GFP	  antibody	  and	  finally	  developed	  by	  Alkaline	  phosphatase.	  MM:	  molecular	  weight	  marker,	  Lane	  1:	  Pure	  extract	  of	  GFP	  which	  is	  a	  27	  kDa	  protein	  (positive	  control),	  Lane	  2:	  wild	  type	  (negative	  control),	  Lane	  3:	  Double	  deletion	  mutant	  (negative	  control),	  Lane	  4:	  ΔHpputP	  mutant	  complemented	  with	  pIB6	  HpputP-­GFP,	  Lane	  5:	  	  Deletion	  Mutant	  expressing	  GFP,	  Lane	  6:	  
ΔHpputAP	  mutant	  complemented	  with	  pIB6	  HpputP-­GFP.	  	  	  





complemented	  mutant	   showed	   a	  maximum	  accumulation	   of	   80%	   compared	   to	  the	  wild	  type	  (Figure	  29).	  Our	   results	   demonstrated	   that	   HpPutP	   is	   the	   proline	   transporter,	   allowing	  proline-­‐specific	   incorporation	   into	  the	  cells.	  Thus,	  we	  could	  prove	  that	  HpPutP,	  which	   was	   previously	   found	   to	   be	   essential	   for	   colonization	   in	   the	   Mongolian	  gerbil	  model	  (Kavermann	  H,	  2003),	  is	  the	  solely	  proline	  transporter	  in	  H.	  pylori.	  under	  the	  condition	  tested.	  
	  
Figure	   28.	   Time	   course	   of	   active	   proline	   uptake	   in	   H.	   pylori	   cells.	   Measurements	   were	  performed	  as	  described	   in	   section	  2.2.2.9.4.	  The	   transport	  data	   corresponds	   to	  200	  µl	  of	   a	   cell	  suspension	   which	   was	   afterwards	   incubated	   at	   37°C	   shortly	   before	   use.	   Reactions	   were	  performed	  with	  simultaneus	  addition	  of	  50	  mM	  NaCl	  and	  10	  μM	  14C-­‐L-­‐proline	  (26	  μCi/μmol)	  and	  stopped	  after	  different	  time	  intervals(0	  sec,	  10	  sec,	  30	  sec,	  1	  min,	  2	  min,	  5	  min,	  10	  min,	  30	  min)	  with	  a	  total	  of	  6	  ml	  potassium-­‐lithium-­‐Buffer.	  From	  the	  filters	  used,	  the	  accumulated	  proline	  in	  the	  cells	  was	  determined	  in	  a	  	  ß-­‐	  Counter.	  	  
	  





30	  sec,	  1	  min,	  2	  min,	  5	  min,	  10	  min,	  30	  min)	  with	  a	  total	  of	  6	  ml	  potassium-­‐	  lithium-­‐	  Buffer.	  	  From	  the	  filters	  used,	  the	  accumulated	  proline	  in	  the	  cells	  was	  determined	  in	  a	  	  ß-­‐	  Counter.	  
	  
	  
3.2.5	  Michaelis-­Menten	  kinetics	  of	  proline	  into	  H.	  pylori	  	  Kinetic	  analysis	  of	  HpPutP	  in	  H.	  pylori	  revealed	  Km	  values	  of	  19.4±6.9	  µM	  and	  a	  Vmax	  of	  2.6±0.26	  nmol/mg*min	  (Figure	  30).	  These	  results	  seem	  to	  correspond	  to	  a	   low	   affinity	   binding.	   The	   proline	   concentrations	   tested	  were	   in	   the	   range	   of	  0.12	  µM	  to	  250	  µM.	  Furthermore	  the	  proline	  kinetics	  showed	  a	  biphasic	  behavior	  that	  could	  represent	  two	  binding	  sites	  in	  HpPutP.	  
	  
Figure	  30.	  Kinetics	  of	  14C-­L-­proline	  uptake	  into	  H.	  pylori	  P12.	  	  The	  reaction	  rate	  v	  (nmol/mg	  min)	   is	   plotted	   (A)	   as	   Michaelis-­‐	   Menten,	   	   (B)	   Lineweaver-­‐	   Burk	   versus	   the	   L-­‐proline-­‐	  concentration,	   which	   lay	   between	   0,12	   µM	   and	   250	   µM.	   According	   to	   Michaelis	   -­‐	   Menten	  calculations	  Vmax	  corresponds	  to	   	  2.6±0.26	   	  nmol/mg*min,	  and	  a	  Km	  of	  19.4±6.9	   	  µM.	  Maximum	  accumulation	  2.3	  µM	  	  	  The	  cation-­‐coupled	  symport	  activity	  of	  HpPutP	  in	  H.	  pylori	  was	  also	  investigated.	  Here,	  kinetics	  of	  Na+-­‐dependent	  L-­‐proline	   transport	   in	  H.	  pylori	  were	  analyzed.	  The	   results	   showed	  Michaelis-­‐Menten	   kinetics	  with	   a	   Km	   of	   1.0±0.5	  mM	   and	   a	  






Figure	   31.	   Na+	   dependence	   of	   proline	   uptake	   into	   H.	   pylori	   P12.	   	   The	   reaction	   rate	   v	  (nmol/mg*min)	  is	  plotted	  (A)	  as	  Michaelis-­‐	  Menten,	  	  and	  (B)	  as	  Lineweaver-­‐	  Burk	  versus	  the	  Na+	  concentration,	   which	   lay	   between	   5	   µM	   und	   250	   mM.	   According	   to	   	   Michaelis	   -­‐	   Menten	  calculations	  vmax	  corresponds	  to	  1.8	  nmol/mg*min	  and	  a	  K0,5	  of	  1±0.5	  	  mM.	  	  	  	  
3.2.6	  Electron	  microscopy	  observation	  of	  flagella	  of	  H.	  pylori	  wild	  type	  and	  






Figure	  32.	  Scanning	  electron	  microscopy	  of	  H.	  pylori	  wild	  type	  and	  complemented	  mutant.	  (A)	  Bacillary	   form	  of	  H.	  pylori	  P12	   (Wt)	  at	  day	  2	   in	   logarithmic	  phase;	   (B)	  bacillary	   form	  of	  H.	  
pylori	  P12	  (Wt)	  at	  day	  2	  in	  logarithmic	  phase;	  (C)	  bacillary	  form	  of	  H.	  pylori	  P12	  ΔHpputP	  at	  day	  2	  in	   logarithmic	   phase;	   (D)	   bacillary	   form	   of	  H.	   pylori	   P12	  ΔHpputP	   +	   pIB6	  HpputP	   at	   day	   2	   in	  logarithmic	  phase.	  	  	  The	   complemented	  mutant	   was	   also	   characterized	   by	   the	   soft	   agar	   assay	   and	  results	  showed	  that	  motility	  was	  reestablished	  (Figure	  33).	  Therefore	  probably	  the	  complemented	  mutant	  needs	  more	  time	  to	  reach	  the	  late	  log	  phase	  and	  the	  flagella	   assembly.	   However,	   as	   the	   typical	   flagella	   bundle	   was	   not	   present,	  further	   electron	   microscopy	   analysis	   at	   later	   growth	   time	   points	   should	   be	  assessed	  for	  the	  complemented	  mutant	  in	  order	  to	  confirm	  this	  hypothesis.	  	  
	  





3.2.7	  L-­proline	  effects	  on	  the	  energy	  status	  in	  H.	  pylori	  Some	   H.	   pylori	   flagellar	   genes	   have	   evolved	   to	   respond	   to	   changes	   in	   DNA	  supercoiling	   in	   response	   to:	   temperature,	   osmolarity,	   pH	   and	   cellular	   energy	  level	  (ATP/ADP	  ratio)	  or	  entry	  into	  stationary	  phase.	  	  It	   is	   known	   that	   the	   assembling	  of	   the	   flagella	   involves	   a	  high-­‐energy	   cost	   and	  this	  could	  explain	  the	  lack	  of	  flagella	  in	  the	  deletion	  mutants	  if	  L-­‐	  proline	  is	  the	  main	  energy	  source	   for	   the	  bacteria.	  For	   this,	  ATP	   levels	  were	  measured	   in	   the	  mutants	  compared	  to	  the	  wild	  type.	  Results	  showed	  a	  highly	  reduced	  amount	  of	  ATP	   levels	   in	   the	  ΔHpputP,	  ΔHpputA,	   and	  ΔHpputAP	  mutants	   compared	   to	   the	  wild	  type	  (Figure	  34).	  
	  






Figure	   35.	   ATP	   levels	   in	   H.	   pylori	   P12	   (Wt),	   ΔHpPutP	   and	   complemented	   mutant	  
(ΔHpPutP+pIB6	  HpPutP).	   	  ATP	   levels	   in	  H.	  pylori	   cells	  were	  measured	  with	   the	  BacTiter-­‐Glo™	  Microbial	  Cell	  Viability	  Assay	  (Promega)	  as	  described	  before.	  NCL	  (Negative	  control	  of	  medium)	  	  
	  
3.2.8	  Transcription	  analysis	  of	  flagellum-­related	  genes	  in	  H.	  pylori	  deletion	  





flhA	   showed	  a	   slight	   variation	   compared	   to	   the	  wild	   type.	   	  By	   contrast,	   class	  2	  genes	   flaB	   and	   flgE	  was	   slightly	   increased	   in	   the	  mutants.	   flaB	   expression	  was	  increased	  approximately	  twofold	  and	   flgE	   fivefold	  compared	  to	  that	  of	  the	  wild	  type.	  Expression	  of	  the	  class	  3	  gene	  flaA	  was	  severely	  decreased	  compared	  to	  the	  wild	  type	  (Figure	  36).	  Reduced	  expression	  of	  this	   important	  structural	   flagellar	  protein	   alone	  would	   certainly	   account	   for	   the	   lack	   of	   flagella	   observed	   on	   the	  mutant.	   Expression	   of	   intermediate	   class	   genes	   flgM	   and	   flhF	   were	   slightly	  downregulated	  compared	  to	  the	  wild	  type.	  	  
	  
	  
Figure	   36.	   Flagella	   gene	   expression	   of	   H	   pylori	   P12	   ΔHpputP,	   ΔHpputA,	   and	   ΔHpputAP	  
mutants	  compared	  to	  wild	  type	  Fold	  expression	  compared	   to	  wild-­‐type	  was	  calculated	  using	  














4.	  DISCUSSION	  	  It	  is	  estimated	  that	  H.	  pylori	  is	  responsible	  for	  5.5%	  of	  all	  human	  cancer	  cases,	  or	  approximately	   592,000	   gastric	   cancer	   cases	   per	   year	   (Parkin	   D	  M,	   2006).	   The	  ability	  of	  H.	  pylori	  to	  live	  in	  the	  stomach	  acidic	  environment	  makes	  its	  physiology	  unique,	  and	  much	  research	  has	  focused	  on	  understanding	  the	  factors	  that	  enable	  this	  bacterium	  to	  survive	  in	  such	  environment.	  	  Besides	  the	  urease	  enzyme	  and	  genes	  involved	  in	  motility	  of	  H.	  pylori,	  only	  few	  further	  genes	  have	  been	  shown	  to	  be	  essential	  for	  colonization	  in	  animal	  models	  (Eaton	  K	  A,	  et	  al.	  1999).	  Kavermann	  H,	  et	  al.	   in	  2003	  used	  the	  signature	  tagged	  mutagenesis	   (STM)	  method	   and	   performed	   infection	   studies	   in	   the	  Mongolian	  gerbil	  (Meriones	  unguiculatus),	  a	  well-­‐established	  H.	  pylori	  animal	  model,	  for	  the	  identification	  of	  H.	  pylori	  genes	  essential	  for	  colonization.	  This	  model	  appears	  to	  be	  most	  suitable	  for	  screening	  as	  it	  has	  several	  advantages	  such	  as	  a	  low	  gastric	  pH	   as	   in	   humans,	   the	   induction	   of	   typical	   gastritis,	   gastric	   ulceration,	   and	  carcinoma	   upon	   infection	   with	   H.	   pylori,	   similar	   to	   the	   situation	   in	   humans	  (Ikeno	  T	  H,	  et	  al.	  1999).	  Among	   the	   genes	   essential	   for	   colonization	  was	   the	   gene	  hpp12_49	  encoding	   a	  putative	  proline	  transporter	  (HpPutP)	  (Kavermann	  H,	  et	  al.	  in	  2003).	  The	  finding	  suggests	  that	  H.	  pylori	  relies	  on	  the	  exogenous	  uptake	  of	  this	  amino	  acid	  from	  the	  stomach	   mucosa.	   Furthermore,	   Nagata	   and	   coworkers	   demonstrated	   in	   2003	  that	   i)	   consumption	   of	   L-­‐serine	   and	   L-­‐proline	   as	   respiratory	   substrates	  stimulates	  rates	  of	  oxygen	  consumption;	   ii)	  H.	  pylori	  cells	  contain	  high	  levels	  of	  L-­‐proline;	  and	  iii)	  gastric	  juice	  from	  patients	  with	  H.	  pylori	  showed	  a	  significantly	  higher	   level	   of	   L-­‐proline	   than	   those	   from	   uninfected	   subjects.	   Taken	   together,	  these	   results	   suggest	   that	   H.	   pylori	   cells	   utilize	   L-­‐proline	   as	   a	   major	   energy	  source	  in	  their	  habitat,	  the	  mucous	  layer.	  
	  
	  





	  Therefore	  transport	  activity	  of	  radioactive	  labeled	  L-­‐proline	  was	  evaluated	  first	  in	  proteoliposomes,	   and	   as	  proteins	  of	   this	   family	  utilize	   a	   SMF	   to	  drive	  uphill	  transport	  of	  substrates,	  ion	  dependency	  was	  also	  assessed.	  	  The	  results	  showed	  that	   proline	   transport	   in	   HpPutP	   seems	   to	   depend	   on	   an	   electrochemical	   Na+	  gradient.	  Na+	  can	  be	  substituted	  by	  lithium	  (Li+)	  but	  not	  by	  protons	  (H+).	  This	  is	  in	  agreement	  with	  data	  reported	  for	  E.	  coli	  where	  H+-­‐driven	  L-­‐proline	  uptake	  by	  EcPutP	   could	   not	   be	   demonstrated	   (Jung	   H	   et	   al.,	   1998a;	   Jung	   H	   et	   al.	   1998b;	  Yamato	  I	  and	  Y	  Anraku,	  1993;	  Chen	  C	  C	  et	  al.	  1985;	  Cairney	  J	  et	  al,	  1984).	  	  Inhibition	   studies	   in	   proteoliposomes	   revealed	   that	   HpPutP	   is	   stereospecific	  recognizing	   only	   the	   L-­‐	   but	   not	   the	   D-­‐isomer	   of	   proline.	   This	   could	   have	   a	  physiological	  reason	  and	  fits	  to	  the	  high	  content	  of	  L-­‐proline	  in	  infected	  samples	  of	  human	  gastric	  juice	  (Nagata,	  et	  al.	  2003).	  Furthermore	  proline	  analogs	  already	  known	   to	   inhibit	   proline	   transport	   by	   EcPutP	   strongly	   inhibit	   also	   HpPutP-­‐catalyzed	  transport.	  This	   indicates	  again	  a	  strong	   functional	  similarity	  between	  both	  proteins.	  The	  analogs	  tested	  were	  dehydro-­‐DL-­‐proline	  (double	  bond	  in	  the	  ring	   structure),	   L-­‐azetidine-­‐2-­‐carboxylic	   acid	   (smaller	   ring)	   and	   L-­‐proline-­‐methylesther	   (alteration	   in	   the	   carboxyl	   group),	   showing	   91.4%,	   86.6%	   and	  88.50%	  inhibition,	  respectively.	  	  The	  next	  step	  was	  the	  analysis	  of	  proline	  uptake	  into	  E.	  coli	  cells	  heterologously	  expressing	   HpputP,	   which	   also	   showed	   complementation	   of	   the	   transport	  activity.	   The	   kinetic	   parameters	   of	   proline	   uptake	   and	   Na+	   dependency	   were	  evaluated	  (Km	  of	  1,3	  µM)	  and	  these	  were	  in	  the	  same	  order	  of	  magnitude	  as	  those	  for	  EcPutP	   	  (kd(Pro)	  and	  Km(Pro)	  of	  2	  μM)	   (Wood	   J	  M	  and	  D	  Zadworny,	  1979;	  Yamato	   I	   and	  Y	  Anraku,	  1993;	   Jung	  H	  et	  al.	   1998).	  Therefore,	  PutP	  of	  H.	  pylori	  seems	   to	   be	   a	   high	   affinity	   L-­‐proline	   transporter	   under	   these	   conditions.	  Furthermore,	  a	  Na+	  concentration	  required	   for	  half-­‐maximum	  stimulation	  of	  L-­‐proline	  uptake	  (k0.5(Na+))	  of	  17±0.9	  µM	  suggests	  a	  high	  affinity	  also	  for	  Na+.	  	  One	   of	   the	   current	  major	   challenges	   in	   the	   investigation	   of	   transporters	   is	   the	  identification	   of	   regions	   involved	   in	   the	   binding	   and	   translocation	   of	   Na+	   and	  substrate.	   Labeling	   experiments,	   random	   and	   site-­‐directed	   mutagenesis	   have	  been	  employed	  to	   identify	   functionally	   important	  sites	   in	  PutP	  of	  E.	  coli,	  where	  substitution	  of	  Asp-­‐55,	  Ser-­‐340	  and	  Thr-­‐341	  dramatically	  reduces	  the	  apparent	  affinity	  for	  Na+	  and	  Li+	  (Hilger	  D,	  et	  al.,	  2008;	  Pirch	  T,	  et	  al.	  2002).	  On	  the	  other	  hand,	  Ser-­‐57,	  Tyr-­‐140,	  and	  Trp-­‐244,	  are	  involved	  in	  proline	  binding	  (Pirch	  T,	  et	  





identical	   structures	   and	   distantly	   related	   sequences	   still	   fold	   into	   similar	  structures.	  This	  relationship	  was	  first	  identified	  by	  Chothia	  and	  Lesk	  in	  1986	  and	  later	  quantified	  by	  Sander	  and	  Schneider	   in	  1991.	   In	  1999,	  Rost	  could	  derive	  a	  precise	   limit	   for	   this	   rule.	   As	   long	   as	   the	   length	   of	   two	   sequences	   and	   the	  percentage	  of	   identical	  residues	  fall	   in	  the	  region	  marked	  as	  “safe,”	  (>40%)	  the	  two	  sequences	  are	  practically	  guaranteed	  to	  adopt	  a	  similar	  structure.	  Therefore,	  as	  EcPutP	  and	  HpPutP	  show	  50	  %	  identical	  amino	  acids,	  is	  highly	  probable	  that	  both	  share	   the	  same	  structure.	  To	  date	   there	   is	  no	  high	  resolution	  structure	  of	  PutP	   or	   any	   other	   L-­‐proline	   transporting	   integral	  membrane	  protein	   available.	  But	   crystallization	   of	   the	   Na+-­‐dependent	   galactose	   symporter	   vSGLT	   of	   Vibrio	  
parahaemolyticus	  (a	  member	  of	  the	  SSS	  family)	  gave	  the	  first	  hints	  (Faham	  S	  et	  
al.	  2008).	  A	  homology	  model	  of	  E.	  coli	  PutP	  was	  generated	  based	  on	  the	  crystal	  structure	  of	  vSGLT	  (Olkhova	  E	  et	  al.	  2011).	  We	  also	  designed	  a	  homology	  model	  of	  HpPutP	  based	  on	  vSGLT	  (Figure	  15).	  This	  model	  shows	  a	  high	  similarity	  to	  the	  EcPutP	   homology	   model	   including	   the	   sites	   of	   proline	   and	   Na+	   binding.	  Therefore,	   this	   observations	   support	   our	   previous	   results	   of	   transport	   when	  amino	  acid	  replacements	  were	  assessed.	  	  All	   the	   data	   recovered	   up	   to	   this	   point	   were	   obtained	   from	   heterologous	  expression	  systems,	  which	  are	  based	  on	  the	  assumption	  that	  the	  basic	  principles	  of	  protein	  expression	  and	   function	  are	   similar	   in	   all	   organisms	   (Frommer	  W	  B	  and	   O	   Ninnemann,	   1995).	   Nevertheless,	   important	   differences	   exist	   between	  cells	  in	  terms	  of	  the	  presence	  and	  composition	  of	  cell	  walls,	  and	  the	  presence	  of	  specialized	  organelles.	  The	  H.	  pylori	  outer	  membrane	  composition	  is	  unique	  in	  its	  protein	  content	  and	  lipopolysaccharide	  (LPS)	  structure	  (Aspinall	  G	  O	  et	  al.	  1996).	  The	   bacterium's	   LPS	   consists	   predominantly	   of	   a	   variety	   of	   the	   tetra-­‐acylated	  lipid	  A,	  which	  is	  known	  to	  exhibit	  1000-­‐fold	  reduced	  bioactivity	  as	  compared	  to	  





	  To	  evaluate	  proline	  kinetics	  in	  H.	  pylori	  (wt)	  we	  conducted	  several	  experiments	  at	   multiple	   substrate	   concentrations	   and	   measured	   initial	   velocity	   at	   each	  substrate	   concentration.	   Results	   showed	   a	   Km	   of	   19.4±6.9	   µM	   in	  H.	   pylori	   that	  compared	   to	   the	   values	  obtained	   from	   the	  heterologous	   system	   (Km	  of	   1.3±6.9	  µM)	   seems	   to	   indicate	   a	   lower	   affinity	   for	   proline.	   Assuming	   a	   stable	   pH,	  temperature,	  and	  redox	  state,	  the	  Km	  is	  constant,	  however,	  a	  possible	  explanation	  for	   this	   discordance	   is	   the	   different	  membrane	   environment	   between	  H.	   pylori	  and	  E.	  coli.	  Furthermore	  meassurements	  were	  performed	  with	  the	  cells	  exposed	  to	  high	  oxygen	  concentrations	  that	  can	  be	  detrimental	  for	  H.	  pylori.	  	  We	  had	  evidence	  that	  the	  accumulation	  of	  proline	  is	  achieved	  in	  the	  presence	  of	  sodium,	   therefore	   measurements	   of	   sodium	   kinetics	   were	   performed	   and	  showed	   a	   K0.5Na+	   of	   1.0±0.5mM.	   Sodium	   concentrations	   in	   the	   sample	  supernatants	  were	  between	  0.07	  to	  0.12	  mM	  and	  attempts	  to	  reduce	  them	  after	  several	  washing	  steps	  lead	  to	  inhibition	  of	  transport.	  According	  to	  our	  results,	  H.	  
pylori	   seems	   to	   respond	   to	   Na+	   concentrations	   in	   the	   milimolar	   range,	   which	  differs	   from	   the	  values	  obtained	  previously	   in	   the	  heterologous	   system	  (K0,5	  of	  	  17±0.9	  µM)	  (Bracher	  S	  and	  H	  Jung,	  unpublished	  data).	  The	  different	  membrane	  environment	   could	  be	  a	   reason.	   	  But	   this	   could	  also	  be	  an	  adaptation	   from	   the	  bacteria	   to	   the	   gastric	   environment	   since	   sodium	   concentrations	   in	   the	   gastric	  juice	  are	  in	  the	  range	  of	  30.2	  to	  69.8	  miliequivalents	  (mEq)	  in	  healthy	  individuals	  or	  higher	  in	  individuals	  with	  chronic	  gastritis	  and	  peptic	  gastric	  ulcer	  	  (Meeroff	  J	  C	  et	  al.,	  1973).	  	  In	  addition,	  salt	  resistance	  can	  induce	  changes	  in	  expression	  of	  outer	  membrane	  proteins,	  such	  as	  the	  transporters	  ProP,	  ProU,	  BetT,	  and	  BetU	  in	  E.	  coli	  (Wood	  J	  M	  2007).	   In	   pathogenic	   bacteria,	   osmotic	   stress	   can	   also	   serve	   as	   a	   signal	   that	  controls	  expression	  of	  virulence	  factors.	  For	  example,	  a	  recent	  study	  showed	  that	  elevated	   salt	   concentrations	   result	   in	  alterations	   in	  expression	  of	   the	  virulence	  factor	  CagA	   in	  H.	  pylori	  strain	  26695	   (Loh	   J	  T	  et	  al.	  2007).	  Furthermore	   recent	  reports	   suggest	   that	   there	   is	   a	   strong	   epidemiological	   link	   between	   high	   salt	  intake	  and	  H.	  pylori-­‐induced	  disease	  (Tsugane	  S	  and	  S	  Sasazuki	  2007).	  Thus,	  the	  bacterium	   could	   sense	   fluctuations	   in	   salt	   concentration	   due	   to	   dietary	   intake	  and	  alters	  its	  growth	  and	  gene	  expression	  accordingly.	  	  	  





the	  yields	  of	  the	  replacements	  among	  selected	  Strr	  colonies	  varied	  from	  ∼17%	  to	  
∼90%,	  depending	  on	  the	  gene	  targeted	  and	  the	  strain	  background	  (Dailidiene	  D,	  





bundle	  was	  perfectly	  visible.	  These	  data	  were	  confirmed	  by	  the	  lack	  of	  swarming	  activity	   in	   the	  deletion	  mutants.	   Furthermore,	   conversion	   to	   the	   coccoid	   shape	  was	   observed	   in	   all	   strains	   at	   the	   stationary	   phase	   (96h).	   	   This	  morphological	  transition	   from	   spiral	   to	   coccoid	  has	   been	   appointed	   as	   a	  manifestation	   of	   cell	  adaptation	  to	  non-­‐optimum	  environments	  as	  the	  bacterium	  moves	  into	  a	  viable	  but	  non-­‐culturable	  state	  (Azevedo	  N	  F,	  et	  al.	  1997).	  Our	  results	  suggest	  that	  the	  
HpputP	   and	  HpputA	  genes	  are	  probably	  necessary	   for	   flagella	  assembly.	  This	   is	  another	   important	   evidence	   that	   proline	   uptake	   and	   metabolism	   are	  determinants	  required	  for	  colonization	  and	  morphological	  changes	  in	  H.pylori	  as	  already	  described	  before	  by	  Kavermann	  H	  et	  al.	  2003	  for	  HpPutP	  and	  Nakajima	  K	  
et	  al.	  2008	  for	  HpPutA	  respectively.	  	  	  Motility	   is	   an	   important	   virulence	   factor,	   as	   no	   colonization	   in	   the	   stomach	   is	  observed	  in	  mice	  infected	  with	  a	  strain	  with	  disrupted	  flagella	  (Eton	  K	  A,	  1999).	  Therefore	   the	  previously	   reported	   failure	  of	  ΔHpputP	   and	  ΔHpputA	  mutants	   to	  cause	  colonization	  may	  be	  due	  to	  the	  loss	  of	  flagella	  and	  therefore	  motility.	  Loss	  of	  motility	  was	  also	  confirmed	  for	  the	  	  ΔHpputP,	  ΔHpputA	  and	  ΔHpputAP	  mutants	  	  by	  the	  soft	  agar	  plates	  assay.	  	  To	   restore	   the	   phenotypic	   effects	   in	   the	  H.	   pylori	  mutants,	   and	   furthermore	   to	  use	   the	   complementation	   system	   in	   transport	   experiments,	   the	   shuttle	   vector	  pIB6	  was	  used.	  Based	  on	  this,	  different	  vectors	  for	  native/constitutive-­‐promoter	  driven	   expression	   were	   created	   using	   GFP	   as	   a	   reporter	   to	   evaluate	   the	  expression	  of	  the	  system	  by	  fluorescent	  microscopy.	  	  	  We	  searched	  for	  differences	  between	  expression	  of	  the	  protein	  under	  regulation	  of	   the	   putative	   native	   promoter	   sequence	   of	   HpPutP	   (to	   identify	   possible	  differences	   in	   gene	   expression	   in	   response	   to	   proline)	   or	   the	   constitutive	  promoter	   alpA	   (Barwig	   I	   2009).	   Plasmids	   derived	   from	   pIB6	   were	   introduced	  into	  H.	  pylori	  by	  conjugation	  to	  overcome	  the	  H.	  pylori	  strain-­‐specific	  restriction	  barriers	  that	  frequently	  lead	  to	  restriction	  of	  plasmid	  DNA	  derived	  from	  E.	  coli	  or	  heterologous	  H.	  pylori	  strains.	  This	  phenomenon	  was	  repeatedly	  observed	  in	  our	  case,	  showing	  complete	  resistance	  to	  transformation	  when	  using	  shuttle	  vectors	  as	  previously	  reported	  (Tsuda	  M	  et	  al.,	  1993;	  Wang	  G	  et	  al.,	  1993;	  Heuermann	  D	  and	  Haas	  R,	  1998).	  	  No	   evident	  difference	   in	   expression	  between	   the	   two	  promoters	  was	  observed	  when	  GFP	  was	  fused	  directly	  behind	  the	  native	  or	  constitutive	  promoter	  region,	  showing	  GFP	  localization	   in	  the	  cytoplasm.	  When	  the	  translational	  HpPutP-­‐GFP	  fusion	  was	  expressed	  with	  either	  of	  the	  two	  promoters,	  the	  protein	  was	  localized	  in	  the	  membrane,	  which	  is	  consistent	  with	  the	  expected	  localization	  of	  HpPutP	  as	  a	  membrane	  protein.	  As	  the	  HpputP	  expression	  in	  the	  putative	  native	  promoter	  did	  not	  need	  an	  additional	  stimulus	  for	  expression,	  if	  L-­‐proline	  is	  the	  triggering	  stimulus	   for	   expression,	   this	   still	   needs	   to	   be	   determined.	   It	   is	   important	   to	  remark	  that	  H.	  pylori	  was	  cultured	  in	  a	  high	  complex	  medium	  containing	  proline,	  therefore	  whether	  proline	  concentrations	  trigger	  the	  expression	  of	  HpputP	  is	  not	  known	   and	   as	  mentioned	   before,	   trials	   to	   reproduce	   a	   defined	  medium	   for	  H.	  





domain	  of	  HpPutA.	  We	  also	  confirmed	  by	  western	  blot	  the	  expression	  of	  HpPutP-­‐GFP	  in	  samples	  from	  H.	  pylori	  membranes.	  	  	  Once	  HpputP	   expression	  was	   confirmed	   by	   a	   second	  methodology,	  we	   focused	  upon	   further	   investigating	   the	   proline	   uptake	   in	   H.	   pylori	   cells.	   Analysis	   of	   L-­‐proline	  uptake	  revealed	  active	  transport	  activity	  in	  H.	  pylori	  (Wt)	  cells,	  while	  in	  the	  deletion	  mutants	  (ΔHpputP	  and	  ΔHpputAP)	  transport	  was	  not	  detected.	  The	  complemented	   mutants	   (ΔHpputP	   and	   ΔHpputAP	   harboring	   the	   plasmid	   pIB6	  
alpA	  HpputP)	  were	   able	   to	   reestablish	   the	   function	   to	   up	   to	   80%	  of	  maximum	  accumulation	  in	  respect	  to	  the	  wild	  type.	  This	  means	  that	  HpPutP	  is	  the	  proline	  permease	  in	  H.	  pylori.	  Thus,	  we	  could	  prove	  that	  HpPutP,	  which	  was	  previously	  found	  to	  be	  essential	  for	  colonization	  in	  the	  Mongolian	  gerbil	  model	  (Kavermann	  H,	  et	  al.	  2003),	   is	   the	  sole	  proline	   transporter	   in	  H.	  pylori	  under	   the	  conditions	  tested.	  Under	  other	  conditions	  ProP	  and	  ProWX	  (potential	  proline	  transporters)	  could	  also	  play	  a	  role.	  	  Another	   important	   question	   is:	   why	   does	   the	   lack	   of	   proline	   in	   the	   ΔHpputP,	  





In	  humans	  collagen	  has	  the	  potential	  role	  of	  storage	  reservoir	  for	  amino	  acids,	  in	  particular	  proline	  (Guszczyn	  T	  and	  K	  Sobolewski,	  2004).	  For	  H.	  pylori	  this	  means	  that	  in	  the	  gastric	  mucosa	  there	  is	  a	  great	  reservoir	  of	  proline	  stored	  as	  collagen	  that	  can	  be	  used	  as	  energy	  source.	  H.	  pylori	  apparently	  relies	  on	  the	  exogenous	  uptake	   of	   amino	   acids	   and	   precursors	   in	   the	   stomach	   mucosa,	   as	   shown	  previously	  for	  growth	  of	  H.	  pylori	  in	  vitro	  (Stark	  R	  M	  et	  al.	  1997).	  	  Such	  an	  amino	  acid	  exchange	  between	  bacteria	  and	  host	  is	  frequently	  observed	  in	  primary	  and	  secondary	  symbionts	  of	  plants	  and	  animals.	  The	  amino	  acid	  dependence	  might	  be	  in	  support	  of	  the	  view	  that	  H.	  pylori	  originated	  as	  a	  commensal	  of	  humans.	  H.	  





In	   conclusion,	   low	   energy	   levels	   due	   to	   the	   lack	   of	   proline	   could	   lead	   to	   DNA	  relaxation,	  downregulation	  of	   flaA	  and	  finally	   loss	  of	  the	  flagella	   in	  the	  deletion	  mutants	   (Figure	   37).	   While	   restoring	   proline	   uptake,	   energy	   levels	   are	  compensated	   and	   the	   flagella	   can	   be	   assembled.	   Therefore,	   in	   H.	   pylori	   the	  control	   of	   transcription	   by	   supercoiling	   could	   also	   be	   intricately	   coupled	  with	  cellular	   energy	   levels	   (ATP/ADP	   ratio)	   (Hsieh	   et	   al.,	   1991;	   van	  Workum	   et	   al.,	  1996;	  Travers	  A	  and	  G	  Muskhelishvili,	  2005b),	  that	  could	  determine	  the	  effective	  superhelicity	  for	  individual	  genes	  or	  regulons	  in	  the	  chromosomal	  DNA	  (Travers	  A	  et	  al.,	  2001;	  Travers	  A	  and	  G	  Muskhelishvili,	  2005).	  	  	  The	   results	   of	   this	   thesis	   showed	   complementation	   of	   the	   HpPutP	   function.	  However,	  due	  to	   the	   lack	  of	   full	   length	   flagella	   in	   the	  SEM	  pictures	  we	  may	  not	  discard	   the	   possibility	   of	   partial	   complementation	   for	   the	   flagella	   assembly	  which	  may	  be	  explained	  by	  pleiotropic	  effects	  of	   supercoil	   relaxation.	  Previous	  reports	  show	  that	  several	  genes	  involved	  in	  virulence,	  such	  as	  cag	  pathogenicity	  island	   genes,	   are	   supercoil	   sensitive,	   reacting	   to	   relaxation	   with	   decreased	  transcription.	   Another	   observation	   connecting	   flagellar	   genes	   and	   supercoiling	  concerns	   the	   proximity	   of	   topoisomerase	   and	   flagellar	   genes	   on	   the	   H.	   pylori	  chromosome:	   topA	   is	   immediately	   adjacent	   to	   flaB,	   the	  minor	   flagella	   subunit	  (Spohn	   and	   Scarlato,	   1999;	   Niehus	   et	   al.,	   2004).	   It	   has	   been	   proposed	   that	  feedback	  mechanisms	  exists	  by	  which	  the	  expression	  level	  of	  flaA	  influences	  the	  expression	   of	   other	   genes	   involved	   in	   flagellar	  motility	   (flaB)	   and	   supercoiling	  (topA)	  (Fang	  Yea,	  et	  al.	  2007).	  Furthermore,	  supercoiling	  in	  H.	  pylori,	  appears	  to	  be	   less	   tightly	   controlled	   compared	   to	   other	   bacteria	   and	   fluctuates	   as	   the	  culture	  passes	  through	  the	  growth	  phases.	  Therefore	  a	  response	  to	  supercoiling	  could	  occur	  at	  many	  levels	  (Hatfield	  G	  W	  and	  C	  J	  Benham,	  2002;	  Travers	  A	  and	  G	  Muskhelishvili,	  2005b)	  and	  this	  could	  also	  be	  happening	  in	  our	  system.	  	  
	  





	  	  	  
	  
	  
4.3	  OUTLOOK	  	  HpPutP	  is	  the	  proline	  permease	  in	  H.	  pylori	  and	  transport	  activity	  depends	  on	  a	  sodium	   gradient.	   However	   for	   a	   deeper	   characterization	   of	   the	   transporter,	  several	  experiments	  still	  need	  to	  be	  performed.	  For	  example:	  	  Calculation	   of	   the	   inhibition	   constant	   Ki	   for	   the	   inhibitors	   tested	   should	   be	  performed.	  Using	  the	  conditions	  optimized	  for	  proline	  transport	  by	  HpPutP,	  we	  could	   determine	   the	   Ki	   of	   the	   available	   proline	   analogs	   and	   determine	   the	  relative	  affinity	  for	  each	  analog.	  	  The	   turnover	   number	   for	   HpPutP	   (the	   number	   of	   substrate	   molecules	  transported	   per	   second	   per	   transport	  molecule	   when	   the	   protein	   is	   saturated	  with	  substrate	  (Nelson	  D	  I	  and	  M	  M	  Cox,	  2005;	  Becker	  W	  M	  et	  al.,	  2006))	  should	  be	  determined.	  	  In	  addition,	  	  it	  is	  important	  to	  unravel	  whether	  HpPutP	  has	  two	  binding	  sites.	  	  Scanning	  electron	  microscopy	  of	  the	  complemented	  mutant	  at	   later	  time	  points	  (growth	  phase)	  should	  be	  performed.	  	  DNA	   superhelicity	   changes	   in	   H.	   pylori	   (mutants	   ΔHpputP	   and	   ΔHpputAP	  compared	   to	   the	   wild	   type)	   should	   be	   evaluated	   based	   on	   the	   experiments	  performed	  by	  Fang	  Yea,	  et	  al.	   in	  2007	   in	  order	   to	   test	   if	  DNA	  topology	  changes	  due	   to	   the	   energy	   status	   of	   each	   particular	   strain	   have	   implications	   on	   the	  flagellar	  gene	  regulation.	  	  It	  is	  also	  important	  to	  analyze	  the	  impact	  of	  HpPutP	  on	  the	  functionality	  of	  other	  virulence	  factors	  of	  H.pylori	  like	  the	  CagA-­‐system	  	  Finally,	  the	  significance	  of	  other	  putative	  proline	  transporters	  (ProP,	  ProWX)	  for	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6.	  SUPPLEMENTARY	  MATERIAL	  
	  
6.1	  Sequence	  alignment	  of	  EcPutP	  and	  HpPutP	  Sequence	   alignment	   of	   HpPutP	   and	   EcPutP	   with	   CLUSTAL	   O	   (1.1.0)	   revealed	  50%	  identical	  amino	  acids	  (suppl.	  Figure	  1).	  Furthermore,	  the	  amino	  acids	  found	  to	  be	  particularly	  important	  for	  EcPutP	  function	  are	  conserved	  in	  HpPutP.	  	  	  
	  
Suppl	   Figure	   1.	   Sequence	   alignment	   of	   EcPutP	   and	   HpPutP.The	   alignment	   was	   generated	  using	   ClustalO	   (1.1.0)	   with	   sequences	   (FASTA)	   obtained	   from	   a	   blast	   search	  (www.ncbi.nlm.nih.gov/BLAST)	  against	  PutP	  of	  E.	  coli	  K12	  (swiss-­‐prot	  entry	  P07117)	  and	  PutP	  of	  H.	  pylori	  P12	   (entry	  HPP12_0049).	  Alignment	  was	  optically	   improved	  by	   the	  Boxshade	  3.21	  program	   (www.ch.embnet.org),	   highlighting	   conserved	   residues	   in	   black	   (50%	   identical	   to	  consensus).	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